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CHAPTER! 
GENERAL INTRODUCTION 
Chapter 1 
1.1. Cancer incidence and the influence of ageing 
Throughout history, cancer has been one of the major causes of death. It has 
been estimated that in the western world approximately one in three people will 
develop some kind of cancer during their lifetime, and one in five will die of it. 
Longevity is associated with prolonged exposure of somatic cells to 
environmental carcinogens leading to carcinogenesis in these ageing cells [40]. 
Therefore, cancer is predominantly a disease related to old age. In The 
Netherlands, the number of persons over 85 years of age increased from 99.000 
in 1976 to 203.000 in 1995 (an increase of !O5 %). It is predicted that by the 
year 2015 the total population living in The Netherlands will have increased by 
8.4%, from 15.4 million in 1994 to 16.7 million [4,34]. However the 
proportion of the population more than 65 years of age is expected to grow 
much faster (45%), although the proportion of persons of 85 years and older 
will remain the same. In view of the demographic developments, the number of 
cancer cases can be expected to increase dramatically in the near future. 
Compared to 1994, for 2015 an increase varying from 30-60 % for cancer of the 
colon, prostate and breast has been predicted [5]. 
1.2. Definition of senescence 
The physiological age of a person is poorly reflected in the chronological age, 
but the chronological age may be used as a frame of reference. Two 
chronological landmarks, that is the ages of 70 and 85 years, seem appropriate. 
Seventy years may be considered as the lower boundary of senescence, because 
the age-related changes start increasing sharply between 70 and 75 years [I]. 
Eighty-five years of age may be considered borderline for the risk of frailty, 
because hearing and vision deterioration cause functional dependence in the 
majority of persons beyond this age [18] and dementia is present in more than 
50% of the individuals over 85 years [8]. 
1.3. Treatment of cancer and the application in the older patient 
Despite the significant progress in the treatment of malignant tumors in the last 
decennia, still 50% of the patients cannot be cured. The 3 main modalities in 
treatment of cancer are surgery, radiotherapy and chemotherapy. The first two 
are generally used alone or in combination in local or locoregional disease. 
Chemotherapy is applied in principle when tumor cells have metastasized from 
the (primary) tumor site to other parts of the body as well as in hematological 
malignancies. Currently, in many patients the different modalities are combined 
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in (neo )adjuvant settings sequentially or even concurrently in order to improve 
the treatment outcome. 
Older patients with cancer are frequently treated less aggressively than their 
younger counterparts and are less likely to receive combined modality therapy 
[10,28]. Patients over the age of seventy-five years are often excluded from 
participation in clinical trials because of concerns regarding toxicity [6,11,39]. 
Kearney e.a. [23] evaluated in a descriptive study the oncology health care 
professionals' attitude towards elderly people. It appeared that, regardless of 
gender, specialty and clinical experience of the professionals, they had negative 
expectations on tolerance for cancer treatments and clinical outcome in elderly 
patients. Another reason for undertreating older patients is the belief that tumors 
are more indolent in the elderly than in younger patients and have a lesser effect 
on life expectancy. However, analyses of tumor stage distribution by age and of 
survival rates of older patients who received less aggressive therapy do not 
support this hypothesis [6,12,38]. 
1.4. Radiotherapy 
Radiation therapy is used in about 50% of all cancer patients. The treatment 
aims include cure (curative radiotherapy), a prolongation of the progression free 
interval, and/or the palliation of symptoms (palliative radiotherapy). Ionizing 
radiation with e.g. high energy photons, electrons or protons are aimed at the 
tumor and the regions with subclinical disease. It causes damage to the DNA in 
the constituent cells of the tumor. If the DNA has been sufficiently damaged, 
the duplication is impeded and cell death ensues at a subsequent cell division. 
Normal tissues are mostly able to repair the sublethal damage inflicted to its 
DNA; cell division is delayed until the DNA is repaired. In general, the repair 
capacity of tumors is less than that of most normal tissues. 
In curative radiotherapy, the total radiation dose is usually given in a so-
called fractionated treatment to take advantage of the differences in repair 
between the tumor cells and normal tissues [13]. 
There are two ways the radiation can be applied: by brachytherapy or 
external beam therapy. In brachytherapy, small radioactive sources are placed in 
or close to the tumor, either by permanent inplants or by inserting catheters or 
applicators that temporarily hold the sources. The tight dose distributions 
restrict the application of brachytherapy to small primary tumors or to the 
booster treatment of only a part of the tumor. In the majority of cases, external 
beam radiotherapy is applied. With external beam radiotherapy, the dose is 
usually delivered by a linear accelerator. 
In clinical practice, the radiation oncologist develops a treatment plan based 
on the characteristics of the patient, the tumor type, extend of the disease and 
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additional prognostic factors. The known tumor extensions and/or the tissues at 
risk for containing tumor cells are defined as the clinical target volume (CTV) 
[22). To compensate for the effects of internal organ and external patient 
movement and inaccuracies in beam- and patient setup, a margin is added to the 
CTV. This volume is defined as the planning target volume (PTV). The 
radiotherapy treatment fields are planned as tightly as possible around the PTV. 
Computer planning systems enable three-dimensional (3D) treatment planning 
using a series of successive 2D images. These images are normally obtained by 
computed tomography (CT) or matched MRI scans. The CT images represent 
the patient anatomy and are used to outline the intended tumor region and 
critical organs. The conformation of individually shaped fields to the specific 
tumor volume with maximum sparing of the surrounding normal tissues in 3 
dimensions is called 3D-conformal radiotherapy. After (virtual CT) simulation, 
the first dose (fraction) of radiation can be applied. Patient position is verified 
using an electronic portal imaging device (EPID). 
1.5. Toxicity of radiotherapy with emphasis on small bowel and rectum 
Despite modern techniques in radiotherapy (RT), irradiation of a tumor 
invariably involves exposure of adjacent structures and may result in significant 
morbidity. Normal tissue tolerance represents the main dose limiting factor. 
The small bowel is one of the most radiosensitive organs in the abdomen and is 
at risk for development of radiation injury during treatment of intra-abdominal, 
pelvic and retroperitoneal tumors. However, the majority of radiation injuries 
are seen in the rectum. Mostly, clinical presentation oflate enteropathy occurs 6 
months to 3 years after completion of therapy [7,16,26]. However, chronic 
changes occasionally develop in continuity with the acute stage of radiation 
injury. Presenting symptoms of late radiation enteropathy are mostly abdominal 
pain, intermittent diarrhea and constipation, sometimes progressing to 
symptoms of total or subtotal obstruction. In late radiation damage of the 
rectum, blood loss and mucous secretion can also be part of the 
symptomatology. 
Histopathological examination of small bowel and rectum with radiation 
induced injury usually shows normal mucosal epithelium at 1-2 weeks after 
treatment. However, local ulceration's may persist for longer periods of time 
[16]. In the early stage, ulcers are usually small and shallow, but chronic 
ulceration's are often larger, with reactive fibrosis extending through the entire 
intestinal wall, causing scarring and stricture formation. Injury of small blood 
vessels is a prominent feature in radiation enteropathy. The morphologic 
changes of blood vessels have been divided into early, intermediate and late 
[25]. In the early phase (hours to a few days after exposure), an inflammatory 
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type of reaction with dilatation of the capillaries is seen [16]. The intennediate 
phase, beginning approximately 4 weeks after irradiation, is characterized by 
patchy destruction and obliteration of capillaries, destruction of endothelial cells 
and focal thrombosis. Plasma proteins accumulate in the blood vessel walls. 
This might be a possible cause of the hyalinization which is typical of late 
arterial lesions and which may progress to total occlusion. Whether acute and 
late intestinal effects are related to cell killing only [37], or that the impaired 
vascular function is the main cause of parenchymal atrophy [15,20,25], is still a 
controversial issue. 
In the intestine, three different alterations result in deposition of collagen in 
the intestinal wall. In the subserosal layer, edema precedes deposition, 
suggesting that vascular injury and/or lymphatic obstruction are important 
pathogenetic factors [16,41]. Fibrosis of the submucosa is not preceded by 
visible edema and seems to be a direct effect of ionizing radiation on 
extracellular material and/or cells elaborating this material. Transmural fibrosis 
of the intestine seems to occur only secondary to chronic mucosal ulceration 
[17]. It is likely that loss of epithelial integrity exposes underlying stroma to the 
detrimental action of various intraluminal contents, eliciting a chronic 
inflammatory response which eventually leads to fibrosis. 
1.6. The influence of ageing on radiation toxicity 
One of the reasons for the obvious difference in cancer treatment of elderly and 
younger cancer patients is the fear that advanced age might be associated with 
reduced tolerance of normal tissues. Progressive reduction of functional reserve 
due to depletion of tissue stem-cells might enhance the damage of normal 
tissues and the risk of complications. Does age per se affect the sensitivity of 
normal tissues to radiation and lead to increased radiation reactions? So far, 
only limited data on this issue are available. Several clinical studies show no 
increased radiation toxicity of normal tissues with age. Radiotherapy of breast 
cancer showed no increased incidence of teleangiectasia, subcutaneous fibrosis, 
arm edema, or lung fibrosis in patients over the age of 60 years and no excess of 
other early or late skin reactions [2,3,36]. The effect of age on acute and late 
reactions during and after radiotherapy was reported by Pignon et al [31]. The 
investigators reviewed data of 1208 patients who had participated in five 
different studies of the European Organization for Research and Treatment of 
Cancer (EORTC). These patients received chest irradiation as monotherapy or 
in combination with surgery or chemotherapy. Acute radiation reactions 
(nausea, vomiting, dyspnea, esophagitis, weight loss and change in performance 
status) and late side effects (dysphagia, esophagitis, spinal cord damage, heart 
damage and radiologically detected changes) were compared in six age groups 
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from less than 50 years old to more than 70 years old. Acute normal tissue 
reactions were not higher in the older group than in the younger patients. The 
mean time for development of late complications, 13 months, was similar in all 
age groups. Forty percent of patients was free of late complications at 4 years, 
with no significant difference among the age groups. Two previous reports by 
the same authors on patients with head and neck and pelvic malignancies, 
treated according to several EORTC-protocols showed similar results [32,33]. 
The strenght of these studies is that all data were recorded prospectively and no 
dose adjustment was made for age. However, all patients had a good 
performance with little functional impairment. Other investigators have reported 
similar results in older patients receiving RT [9,21,35]. The available data on 
the sensitivity of normal tissues to RT in elderly patients strongly suggest that 
older patients with good functional status tolerate radiotherapy as well as 
younger patients, with tumor responses and survival rates quite comparable to 
those of younger groups. Data on older patients with considerable functional 
impairment are even more sparse, and no conclusions can be based on them. 
1.7. Experimental data on ageing and tolerance of normal tissues 
Limited experimental data are available addressing the influence of age on 
radiation sensitivity. Most studies concern early skin reactions in experimental 
animals and do not show an increase of radiosensitivity in older age [24,27,29]. 
Holt e.a. [19] observed a greater rate of proliferation of crypt cells in the 
duodenum, jejunum and ileum in senescent rats than in young mature animals. 
This increase in small intestinal cell production results from a combination of 
an increased percentage of cell cycling at any time and larger crypts. The 
proliferative zone appears to be much wider and extends much further up the 
crypt from the base in aging animals than in the young group. Hamilton [14] 
studied the regeneration of colon crypt cells in young and old mice after single 
dose and fractionated RT. The cell survival in the crypts after irradiation 
appeared to be identical, although the size of the regenerating crypts was larger 
in the old group. Most of the available data on the relation between aging and 
radiation tolerance of normal tissues concern acute reactions. Experimental data 
on the late effects of irradiation in relation to age are rare, especially for a 
radiosensitive organ as the intestine. 
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1.8. Application of conformal radiotherapy to reduce the hazards of 
radiation toxicity 
Conformal radiotherapy enables the radiation oncologist to make an individual 
treatment plan. conformed to the specific tumor volume with maximal sparing 
of the surrounding tissues. The benefits can be used in two ways: first, 
reduction of the risk on normal tissue complications without reduction of the 
tumor control probability and, secondly, escalation of the dose to increase cure 
rates without increasing complication rates. Reduction of the risk on normal 
tissue toxicity is only possible if the mechanism of development of such toxicity 
as well as the different ways of healing of the the inflicted damage and the 
effects of an irradiated (part of the) volume of the organ are clearly understood. 
Understanding of the development of radiation injury makes modulation by 
radioprotective agents possible. In the light of the expected increase of elderly 
cancer patients who will need radiotherapy, more clinical and experimental data 
on the risk of normal tissue complication with older age are needed. 
Furthermore, if we want to reduce the risk of toxicity of surrounding tissues, 
we can make use of all the technical improvements of the recent years for 
maximal sparing of the normal tissues. For 3D-conformal therapy, a definition 
of the CTV as precise as possible, based on all available information such as 
physical examination, surgical report and radiological findings, is needed. 
Consensus between radiation-oncologists about elective treatment of regional 
areas to be treated and their anatomical location, is extremely important. As is 
also stressed by Nowak et al. [30], a three dimensional CT-based target 
definition of elective regions has to be defined for each tumor site. Research on 
internal movement of the CTV by influence of breathing, filling of surrounding 
organs as well as the external positioning variation of the patient is needed to 
define the minimal margin for the PTV. Treatment planning techniques and 
linear accelerators equipped with multileaf collimators have been developed to 
obtain an isodose distribution as tight as possible around the PTV. Finally exact 
daily patient positioning, verification of patient set-up and off-line and/or on-
line correction of the set-up is a prerequisite for conformal radiation treatment 
of cancer patients. 
1.9. Purposes of this thesis 
Small bowel and the rectum are two important dose limiting normal tissues in 
RT of frequently occurring malignancies such as cervical-, endometrial-, 
prostate- and bladder cancer. Especially as the incidence of these tumors 
increases with age and experimental data on (histopathological) effects of RT 
injury in relation to age are rare, histological studies on the development of 
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radiation induced changes in the rectum of young and old Wistar rats were 
performed. In Chapter 2 the early effects at I, 2, 4, and 10 weeks after single 
doses of radiation are described. The late histological changes at 24 and 52 
weeks after treatment are reported in Chapter 3. 
The following chapters mostly concern reduction of toxicity by application 
of new treatment techniques which are applicable but not restricted to elderly 
patients. Because postoperative RT in node-positive cervical cancer is standard 
treatment in most oncology departments, we made an inventory of the CTV and 
field borders among several experienced Dutch radiation-oncologists and 
compared these to a reference CTV, based on Iymphangiograms and CT-scans. 
In Chapter 4 the differences between physicians, the relationship to the 
reference volume and the implications for the margins between PTV and field 
borders are discussed. In Chapter 5 a 3D-conformal treatment technique for 
node-positive cervical cancer in comparison to the conventional treatment with 
parallel opposing fields is described. Sparing of the small bowel and to a lesser 
degree the rectum were the most important issues in this study. 
A study on the reduction of irradiated small bowel volume using a belly 
board device in pelvic radiotherapy of gynecological cancer patients is 
described in Chapter 6 as well as the implications of this device for patient 
positioning. An off-line correction protocol was used in this study. In Chapter 
7, the early experience regarding on-line set -up corrections in patients with 
gynecological tumors is reported. The general discussion (Chapter 8) 
summarizes the main findings of our studies and discusses the implications of 
these and further studies in clinical practice. Future directions of geriatric 
radiotherapy and application of conformal treatments in order to reduce the risk 
of toxicity, are discussed in relation to our observations. 
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Chapter 2 
Abstract. 
Background and purpose: Radiation treatment of the elderly (> 75 years) is 
often modified due to an assumed decrease in normal tissue tolerance in this age 
group. Since more radiobiological data concerning normal tissue toxicity as a 
function of age are needed, a histological study of age related radiation changes 
of the rectum was performed. 
Material and methods: The rectum of young and old female Wistar rats (12 and 
78 weeks respectively) was irradiated with single doses of 22 Gy and 39 Gy. 
The field size was 1.5 x 2.0 cm. The animals were sacrified at 1, 2, 4 and 10 
weeks after treatment. To evaluate radiation damage, 12 histological parameters 
were scored in four areas of the rectum. A total radiation injury score was 
calculated. The number of proliferative epithelial cells was evaluated by BrdU 
labeling. 
Results: Some age related histological differences were observed; especially the 
incidence of ulceration and vascular occlusion was higher in the older group. In 
the low dose group of the older animals 60 % showed ulceration, which was 0 
% for the young low dose animals. Severe vascular changes occurred early and 
were more extensive in older animals (4 weeks) than in the younger group (10 
weeks). In the area adjacent to the treatment field cell proliferation increased 
significantly in older rats at 1 week after 22 Gy, which did not occur in the 
young group. 
Conclusions: Discrete radiation-induced histological differences were observed 
between the rectum of young and old Wistar rats, especially in the development 
of ulceration and vascular changes. Although the survival of these Wistar rats in 
earlier studies was not affected by age [19], the impact of the observed 
histological differences for their importance in the long term is currently being 
investigated. 
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Introduction 
In most radiotherapy departments, elderly patients constitute the majority of 
patients to be treated [1,25]. A further increase in the average age of cancer 
patients is expected for the next decades for demographic reasons due to 
improvement of general health care as well as the age-dependent incidence of 
most malignant tumors [II]. In the application of curative radiotherapy for elderly 
patients, the treatment is often modified, because of an assumed decrease in 
normal tissue tolerance in this age group. From clinical studies, evidence is 
accumulating that normal tissue toxicity of radiation therapy depends on the 
functional status of the normal tissues that surround the tumor and not or very 
little on chronological age [1,9,21,26]. Only limited radiobiological data are 
available regarding the influence of age on radiation sensitivity [26]. Since the 
rectum is an important dose-limiting organ in radiotherapy of urogenital tumors, 
which occur frequently in these age groups [S,IO], a histopathological study was 
carried out. For this purpose the rectum of young and older rats was irradiated and 
histological changes were studied in time to obtain detailed information on the 
progression of rectal injury. In this study the results of the early time points (up to 
10 weeks after treatment) are presented. Late changes with time points of 24 and 
52 weeks are currently being investigated. 
Materials and methods 
Laboratory animals 
Female Wistar rats, aged 12 and 7S weeks, were used (Harlam Zeist, the 
Netherlands). This allowed a follow up time of 52 weeks in the majority of 
animals. 
They were housed under conventional conditions with food and water ad 
libitum in light controlled rooms (light on at 06.00 h, off at IS.OO h). The 
experimental protocol was approved by the Animal Ethical Committee of the 
University of Rotterdam. Upon arrival the rats continued on their previous diet 
and were allowed to recover fully, as judged by a return of body weight toward 
that on arrival. Young rats weighed approximately 220 g, whereas the older 
animals had an average weight of 350 g. 
Experimental desigll 
Forty female rats in each age group were irradiated with single doses, 20 with 22 
Gy and 20 with 39 Gy. These doses represent the LD20 and LDSO level, 
respectively, for the clinical end point of a macroscopic megacolon (unpublished 
data). At I, 2, 4 and 10 weeks after irradiation 5 rats of each irradiated group were 
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sacrified. For each time point 3 non-irradiated rats of the same age, housed under 
the same conditions and sacrificed simultaneously, acted as controls. 
Irradiation procedures 
The animals were anesthesized with Ketamine [Parke -Davis] intraperitoneal (30 
mglkg body wt. for young and 40 mg/kg body wI. for old rats) and Xylazine 2 % 
[Bayer AG] subcutaneous (5 mg/kg). The control animals were treated with the 
same anaesthesia and were sham-irradiated. 
Irradiation of the rectum was performed with a Philips 250 RT Orthovolt X-
ray machine, operating at 200 KV and 20 rnA. The dose rate at the level of the 
rectum was 1.36 Gy/min for the young animals and 1.25 Gy/min for the older rats, 
due to the difference in skin- rectum distance as a result of overlying fat tissue. A 
Cu filter of I mm was used (HVL 1.6 mm Cu). The focus- skin distance was 30.5 
cm. During irradiation, the head, thorax, upper abdomen and limbs were shielded 
with lead. The field size was 1.5 x 2.0 cm, with the lower border above the 
orifices of vagina and urethra to avoid acute epithelial toxicity of the tissues. 
Previous experiments with fluoroscopic evaluation of the field size have shown 
that the lateral borders of the field are located at the medial side of the hip joints. 
Quality control was performed with thermoluminiscency dosimetry catheters 
(TLD) in the rectum of 50% of randomly assigned animals. 
Proliferative eel/labeling 
To label proliferative cells, animals were given 50mg/kg body weight of 5-bromo-
2' -deoxyuridine (BrdU) [Sigma], 45 minutes before sacrifice. 
Histology 
Following sacrifice of the animals the entire rectosigmoid (± 5 cm) was removed, 
examined macroscopically and fixed in 3.7 % formalin for maximal 24 hours. The 
specimen was sliced transversely in four pieces of 0.4 cm each. These four slices 
of the rectum were embedded in one block; a) between the anus and the irradiated 
area (0 - 0.4 cm), b) caudal part of the irradiated area (0.8 - 1.2 cm), c) cranial part 
of the irradiated area (1.2 - 1.6 cm) and d) above the irradiated area (3.1 - 3.5 cm). 
Three of these slices were marked with different colours of dye. The specimens 
were routinely processed and embedded in paraffin. Sections were cut 5 11m thick 
and stained with hematoxylin-eosin (HE), periodic acid Schiff + reagent (PAS + ), 
Sirius red (SR) and resorcin fuchsin (RF) according to standard methods. 
Immunohistochemistry 
For immunohistochemical studies, antibodies recognizing the following antigens 
were applied: Collagen III (Coil Ill) [Biogenex], 5-bromo-2' -deoxyuridine (BrdU) 
[Becton Dickinson], neurofilaments (NF) [Dako] and S-IOO protein [Dako]. 
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Sections, 4 !lm thick were reacted with appropriate dilutions of antibodies 
after blocking with H20, and antigen retrieval with citric acid. Antigens were 
visualised using a streptavidin-biotin peroxidase conjugate system [Biogenex]. 
Scoring system 
Based on the Radiation Injury Score introduced by Hauer-Jensen and co-workers 
[16], a semiquantitative histopathologic radiation damage score appropriate for 
this experimental setting was developed and used to assess radiation injury. 
Parameters were chosen for the possibility to score them present or absent, for 
their representation of changes in the different layers of the colon wall (mucosa, 
submucosa, muscularis), and for their representation of acute as well as chronic 
injury (for instance ulceration versus squamous metaplasia). The various 
parameters as changes of epithelial cells, crypt distortion, discontinous muscular 
mucosae, mucosal ulceration, squamous metaplasia, hyperplasia, colitis 
glandularis cystica profunda and adenocarcinoma were scored present when 
observed in either part of the section (see also Figure 2-1 and 2-2). Parameters as 
hyalinization of blood vessel walls and occlusion of blood vessels were scored 
present when observed in one or more of the blood vessels of the section (see also 
Figure 2-3). Furthermore the lumen was scored normal if star shaped and 
abnormal if circular shaped. The thickness of the submucosa was scored normal 
or broadened in relation to the submucosa of the non-irradiated part of the rectum. 
For the radiation injury score (RIS) the scores of the above mentioned 12 
parameters were summated. 
For each animal these parameters were scored in all four pieces of the rectum. 
Within the treatment field, a parameter was considered to be present when 
observed in at least one of the two slices of the radiation field. To describe the 
extent of the radiation-induced changes, the presence of a parameter in both of the 
sections of the treatment field was evaluated separately. 
All sections were evaluated by two investigators independently (MJJ. 0.-
v.A. and M.L.F. v.V.) without access to the treatment code. Discrepancies were 
discussed and the final score was determined by consensus. 
Proliferating cells were counted as the number of BrdU positive nuclei in 10 
randomly selected crypts in all four sections. The cell counts obtained by the two 
investigators were averaged. Afterwards the mean of the two sections of the 
treatment field was calculated. Based on survival data of proliferating cells of 
large intestine after irradiation [2,3], we have analysed proliferation one week 
after treatment in more detail and compared these data with the control group and 
the later time points of 4 and 10 weeks after treatment. 
Data analysis 
The incidence of each histopathological parameter in all sections was calculated 
separately for each age group and each time point. Within the treatment field 
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incidences were calculated for presence in either one of the sections and 
separately for presence in both sections. A summation of all present parameters 
was calculated for each animal to obtain a quantitative injury score for the 
sections within the treatment field as well as for the sections above and below the 
field. Per group of animals the mean of the injury score (± sem) was calculated 
according to age, dose and time point. 
Statistical comparison of data was performed with a logistic regression 
analysis for each histological parameter separately; for this purpose the data of all 
4 time points were pooled together. The histological parameters were the 
dependent variables and dose and age were the independent variables in the 
analysis. The total injury score and the number of proliferating cells were 
compared by the analysis of variance test (ANOV A; single factor), using the MS 
Excell 97 program. In all cases, a significance level of 5 % was used. 
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2-1A 
2-1B 
2-1C 
Figure 2-1 
Nonnai 0)1)t architecture of the rectum of a young untreated animal (A), cryptdistorsion qf a young 
animal after 22 Gy a14 weeks (B) and colitis glandularis cystica profunda of a young rat after 22 Gyat 
JO weeks (C). Hematoxylin-eosin staining. Magnification JOOx(A), 200x(B) and 200x(C). 
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2·2A 
2·2B 
2·2C 
Figure 2~2 
Normal star shape of lumen of the rectum of a young untreated animal (A), ulceration with loss of crypts 
ofa .voung animal at 4 weeks after 39 G.v (B) and hyperplasia of tile section above the treatment field of 
the same animal (C). HematmO''"ylin-eosin staining, 50x. 
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2·3A 
2·38 
2·3C 
Figure 2·3 
Normal blood vessels of the lamina propria of the rectum of all old untreated anillml (A), occlusion and 
hyalinosis of the blood vessels of an old animal at 10 weeks after 22 Gy (B) and magnification of 
hyalinosis of one of the blood vessels of the same animal (C). Periodic acid Schiff+ staining, 
magnification lOOx(A), lOOx(B) and 400x(C). 
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Results 
Dosimetry with TLD-measurements showed on average a small difference of 
minus 4.4 % (SD ±1.5) between measured and planned dose. 
Control animals did not show any histopathological alterations at either of the 
four time points (injury score was 0), except for one animal of 78 weeks which 
showed an abnormal shape of the lumen and hyalinosiS of the blood vessel walls. 
Only one rat (of the older age group) died due to severe acute toxicity, i.e. 
ulceration of a major part of the mucosa within the treatment field, 3 weeks after a 
dose of 39 Gy. All other animals could be evaluated. 
Incidences of all parameters, present at the different time points after 
treatment within one or more of the sections of the irradiated part of the rectum, 
are shown in Table 2-1. 
Histopathological parameters 
Below the irradiated area a normal star shaped lumen of the rectum was observed 
in nearly all animals (Figure 2-2A). An abnormal shape mainly concerned a 
circular shape of the lumen. As is shown in Table 2-1 an abnormal shape of the 
lumen frequently occurred after the high dose at 2 weeks and longer without 
significant differences between the young and old rats. 
Disappearance or flattening of epithelial cells outside the irradiated area was 
observed in only one animal, at the anal part of the rectum at I week after 22 Gy. 
Within the irradiated area, after both doses, the incidence was maximal in both 
age groups at I and 2 weeks after treatment. These epithelial changes decreased at 
4 and 10 weeks in the young rats, while the incidence of epithelial changes after a 
dose of 39 Gy was still maximal at 10 weeks in the older age group (difference for 
all time points summated was not significant). 
Ulceration was observed in the irradiated area only (see Figure 2-2B). In the 
younger group no ulceration was observed after a dose of 22 Gy. In older rats 
however, ulceration was present after a dose of 22 Gy, already after 2 weeks and 
increased to an incidence of 60 % at 4 weeks (difference for all time points 
summated was not significant). 
Changing of the architecture of crypts (crypt distortion) was observed in the 
irradiated area only (see Figure 2-IB). One week after irradiation, crypt shape was 
changed within the treatment field, corresponding with acute epithelial changes. 
These early changes of shape were not scored as crypt distorsion. At 2, 4 and 10 
weeks irregular crypts were observed, repopulated with normal epithelial cells. 
Only these architectural changes were scored as crypt distortion. In cases with 
severe ulceration, no crypts were left, and distortion was not assessed. 
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Table 2·l. 
Incidence of various histological parameters in the rectum of young and old rats within the 
treatment field, as well as hyperplasia in and/or rostral of the irradiated field, in relation to dose 
at 1,2,4 and 10 week(s) after treatment (RT). Total number of animals in each group was 5. 
except for the group of rats of 78 weeks after 39 Oy at 4 and 10 weeks; total evaluable number 
was 4 animals. l 
Age (wks)! 
121 22 781 22 121 39 781 39 
Dose (Gy) 
Wksafter RT 1 2 4 10 1 2 4 10 1 2 4 10 1 2 4 10 
Ahll. sh. IUII/ell 5 3 3 3 2 
Epith. cilanges 5 5 4 2 5 4 4 4 5 5 5 3 5 5 4 4 
Mue. ulceration 3 4 4 3 4 3 
Cr)pl distort. 5 5 5 4 5 5 3 3 2 4 
Discoll. muse. 2 3 
Hyperpl. 3 3 
Hyalinosis 4 5 5 5 5 3 4 
Occ!usi(1I1 3 5 3 2 
Iller. SUiJl1llle. 3 4 2 5 2 5 2 5 5 5 3 5 3 4 
Colitis gl. cyst 2 2 2 
j Histopathological parameters were abnormal shape of lumen, epithelial changes. mucosal ulceration. crypt 
distortion, discontinuous muscular mucosa, hyperplasia. hyalinization and occlusion of blood vessel walls, 
increase of thickness of submucosa and colitis glandularis cystica profunda. Metaplasia and carcinomas were not 
observed within these time points. 
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Crypt distorsion in one or both of the sections within the treatment field was 
observed in all animals after a dose of 22 Gy at 2, 4 and 10 weeks, regardless of 
age (Table 2-1). At 4 weeks after 39 Gy, crypt distortion was observed in 60 % of 
the young animals, which decreased to 20 % at 10 weeks. For the old rats this 
incidence was 100 % at 4 weeks, decreasing to 75 % at 10 weeks (difference for 
all time points summated was not significant). 
A discontinuous muscularis mucosae, replaced by collagen or inflammatory 
infiltration, was observed in the irradiated area only, and only at 10 weeks after 
irradiation. In young animals this parameter was observed only after 39 Gy, while 
in old rats this discontinuity was observed after 22 Gy as well (difference for all 
time points summated was not significant). 
Squamous metaplasia as replacement of columnar epithelium by squamous 
epithelial cells was not observed in any of the animals up to 10 weeks after 
irradiation. 
Hyperplasia rostral of the irrradiation area (see Figure 2-2C) was observed in 
60 % of the young animals after a dose of 39 Gy at 10 weeks after the treatment 
and not in the older group (difference not significant). The presence of this 
parameter corresponded with the macroscopic observation of a megacolon and 
partly with ulceration. In only two young animals ulceration was observed without 
adjacent hyperplasia and without macroscopic megacolon. 
Thickening of the blood vessel wall by hyalinization in the lamina propria, the 
submucosa or the muscularis extema resulting in stenosis of the lumen was not 
observed outside the irradiated area. Hyalinization of the wall of blood vessels 
within the irradiated area (see Figure 2-3B and 2-3C) was observed after both 
doses, already at 4 weeks in both age groups. In the younger group a decrease to 
60 % at 10 weeks was found while in the older group the incidence at 10 weeks 
was still maximal (difference for all time points summated was not significant). 
In cases of extreme hyalinization, complete occlusion of one or more of the 
blood vessels in the section could occur (see Figure 2-3B). This phenomenon was 
not observed outside the irradiated area nor in the control animals. Occlusion of 
blood vessels occurred in the young animals only at 10 weeks (Table 2-1). In the 
older group, already after 4 weeks, occlusion occurred in 50 % of the animals 
after 39 Gy. Occlusion of vessels was more extensive in the older group; it was 
usually observed in both slices of the irradiated area. This is in contrast with the 
occlusion observed in the young group, which occurred mainly in only one of the 
sections within the treatment field (p = 0.004 at 10 weeks after treatment). 
From I week after irradiation with either 22 Gy or 39 Gy, an increase in 
thickness of the submucosa of more than 100 % was already observed in both age 
groups within the irradiated part of the rectum, which decreased gradually in time. 
The distance between collagen fibres was enlarged, probably by edema. This 
occurred most frequently in both sections within the treatment field and after both 
dose levels. 
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As long as the rectum wall was not destroyed due to ulceration, ganglion cells 
were evenly distributed in each slide in all animals. Proliferation of 
neurofilaments was not observed. 
There were no adenocarcinomas observed in this study. At 4 as well as 10 
weeks after a dose of 22 Gy, colitis glandularis cystica profunda was found in 
40% of the old animals. In the younger rats colitis glandularis cystica was 
observed in 40 % of the rats, after 22 Gy at 10 weeks only (see Figure 2-1 C). 
After 39 Gy, this parameter was not observed in any of the animals. 
Total radiation injury score 
In Table 2-2 the mean summation of all parameters present per age group is 
shown for the irradiated area. The mean summation was significantly dose related 
for the young animals at 1,2 and 4 weeks (p- value resp. 0.04, 0.003 and 0.03). 
For the young rats at 10 weeks, and for the older group as a whole, there was no 
significant relationship with dose. 
The group of young animals at 10 weeks, treated with 39 Gy, showed a large 
standard deviation due to two animals with extensive damage while in the other 
animals of this group almost no changes were observed. 
Analysis according to age groups indicated that the older group had a 
significantly higher total radiation score at I week after 22 gy (p = 0.04), while the 
younger group had a significantly higher total score at 2 weeks after 39 Gy (p = 
0.003). At all other time points, there were no significant differences. 
Number of proliferating cells 
The mean number of proliferating cells per 10 crypts at one week after treatment 
is shown in Figure 2-4 for the different areas of the rectum. In comparison to the 
control animals, in the younger group a decrease of proliferating cells was 
observed within the treatment field, which was dose related (but not significant). 
In the older group however, an increase in proliferating cells was observed within 
the treatment field after 22 Gy (not significant). Furthermore, the number of 
proliferating cells in the adjacent unirradiated parts of the rectum increased 
significantly in the older group in comparison with the controls. Between the anus 
and the irradiation field this increase at 1 week was marked in the low and high 
dose group (p- value resp. 0.04 and 0.05). Rostral of the treatment field the 
proliferating cells also increased significantly in the old rats after 22 Gy and 39 
Gy (p- value resp. 0.05 and 0.04). This phenomenon was not observed in the 
young animals. 
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Table 2-2. 
Mean total radiation injury score (±SD) of all 12 histological parameters in the rectum of 
young and old rats, as assessed in the treatment field, in relation to dose and time after 
irradiation. 
Age (wks)1 Dose (Gy) 12/0 78/0 121 22 78/22 12/39 78/39 
1 week after RT 0 0 lA±0.5 2.2 ± 0.4 2.2 ± OA 2.0 ± 0.0 
2 weeks after RT 0 0 2.6 ± 0.5 2.4 ± I.7 4.6 ± 0.9 2.6 ± 0.5 
4 weeks after RT 0 0.7 ± 1.2 3.4 ± 0.9 5.0± 1.4 5.0 ± 1.0 5.6 ± 1.1 
10 weeks after RT 0 0 3.8 ± 1.6 5.2 ± 2.2 4.4 ± 4.0 6.0 ± 0.8 
In Figure 2-5 the mean number of proliferating cells within the treatment field 
is shown for all time points. The control animals in the two age groups showed no 
differences in BrdU-positive cells. In the low dose group however the older 
animals not only showed an increase in proliferating cells in comparison with the 
young animals one week after irradiation, but also after 4 weeks (not significant). 
At 10 weeks no differences between young and old rats were observed anymore. 
The number of proliferating cells after 39 Gy was not assessed, because most of 
the animals developed extensive ulceration which did not permit evaluation of 
enough crypts. 
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Mean number of proliferating celis per 10 crypts in the rectum of 
young and old rats at 1 week after treatment as a function of dose, 
and in relation to the position in the treatment field. Error bars 
indicate standard deviations. 
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Figure 2-5 
Mean number of proliferating cells per 10 crypts in the rectum of 
young and old control animals, as well as after 22 Gy, as a function 
of time after irradiation. Error bars indicate standard deviations. 
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Discussion 
When cancer treatment of elderly patients is concerned many physicians tend to 
perform pretreatment selection. In radiation therapy the assumption that normal 
tissue tolerance decreases with increasing age is the basis for undertreatment in 
the elderly. Recent clinical studies on this subject strongly support the idea that 
tissue toxicity in patients older than 74 years is not increased compared with 
younger patients [9,21,22,26,30]. However only limited experimental data are 
available addressing the influence of age on radiation sensitivity. Studies on early 
reactions of normal tissues in experimental animals, usually studying skin 
reactions, do not indicate an increase ofradiosensitivity with older age [12,17,18]. 
Despite the fact that the rectum is an important dose limiting organ in 
radiotherapy in pelvic malignancies, and radiation induced complications of the 
rectum can easily occur [5,13,14, IS, 16,20,23,24,29], studies on radiosensitivity of 
the rectum in relation with age are rare. In previous experiments with single doses 
of irradiation we demonstrated that there was no significant difference in the 
incidence of rectal stenosis resulting in a megacolon between young and older 
rats, using clinical and radiological endpoints. The latency period for development 
of rectal stenosis was 11.6 ± 6.2 weeks after irradiation in young rats and 15.0 ± 
3.9 weeks after irradiation in older animals [19]. To study differences in reaction 
patterns between young and older rats and to elucidate the changes leading to this 
megacolon, rectal tissue was examined histologically I, 2, 4 and 10 weeks after 
irradiation. Two radiation doses equivalent to the LD20 and LD80 were applied. 
We compared histological changes occurring after irradiation in young (12 
weeks) and older (78 weeks) female Wistar rats. 
Age related histological differences were observed, which were only trends 
and mostly not statistically significant in the analysis of the histological features 
separately. Probably due to the limited number of animals these trends were not 
significant. A different kind of reaction pattern might underlie these small 
differences. All young animals in the low dose group showed a continuous 
muscularis mucosae without ulceration, while in the low dose group of old 
animals both ulceration and a discontinuous muscularis mucosae was seen in up 
to 60 % of the rats. In contrast, in the high dose groups ulceration was observed 
already I week after irradiation in the young animals and only at 4 weeks after 
irradiation in the older group. Severe vascular changes (occlusion of blood 
vessels) occured significantly more often in both sections of the irradiated area 
and earlier in the older animals (4 weeks) than in the young animals (10 weeks). 
Dose dependency of damage was reflected in the total injury score, particularly in 
the young animals. The lack of dose-respons relationship in the older rats might 
be explained by the fact that the differences in injury score in these animals are 
above the discrimination threshold with doses of 22 and 39 Gy. Another 
explanation could be the limited number of animals, but this seems unlikely 
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because a significant dose-respons relationship was observed in the young groups 
at 1, 2 and 4 weeks after treatment The injury score of the young animals was 
significantly higher than for the older rats, 2 weeks after irradiation in the high 
dose group (p = 0,003), but this tended to be lower at 4 and 10 weeks after 
irradiation, 
The histological changes gave a few clues concerning the pathogenesis of a 
megacolon. A megacolon can have different etiologies: toxic, in the context of 
severe ulceration and bacterial infection [20], or obstructive as can be observed in 
innervation disorders [4]. Histologic signs of an innervation disorder were not 
seen in this study: ganglion cells were evenly distributed in each section as long as 
the rectum wall was not destroyed due to ulceration. Furthermore, neurofilament 
proliferation was not observed. All animals with a macroscopically observed 
megacolon had ulceration, but never outside the radiation area, making a toxic 
etiology improbable. Many animals with extensive ulceration did not develop a 
macroscopic megacolon within 10 weeks after treatment. According to Trott e.a. a 
high dose to the rectosigmoid does not inevitably lead to the fatal chronic 
radiation ulcer and large bowel obstruction, but several other factors, as fecal 
abrasion, might cause mechanical damage to the chronically atrophic mucosa, 
subsequently leading to ulceration and eventually to obstruction [27,28]. 
Ulceration is an important feature as it showed a clear dose, age and time 
dependency. It appeared to be reversible in some cases. We can only speculate on 
the factors determining the reversibility of ulceration. According to Trott e.a. [28] 
healing of a lesion occurs if no additional damage interferes, but healing of a 
manifest ulcer cannot reconstitute the original tissue structure, but leads to 
defective healing with scar formation, dystopic epithelial proliferation and 
thrombosed vessels. Vascular changes might influence the regenerative capacity 
of the mucosa. Especially vascular occlusion was observed more often in older 
rats. 
Proliferation of epithelial cells is a factor of importance in wound healing. 
This was measured by BrDU labeling. Holt e.a. [6,7] showed that proliferative 
patterns in small intestine and colon have a broadened proliferative zone in 
senescent rats and that the small intestinal cell production can be enhanced by 
nutritional factors in comparison with young animals. In our study, the number of 
proliferative cells in the rectum adjacent to the treatment field in the older group 
increased one week after 22 Gy. However at 4 and 10 weeks after treatment 
differences in proliferating cellnumbers between young and old animals were not 
significant. The mucosa of young animals adjacent to the ulceration showed 
hyperplastic changes. Although these changes were not related to proliferation, 
the hyperplastic changes might reflect a regenerative proces of the mucosa in the 
younger animals. 
Fibrosis did not occur in the course of this study. The mucosa and submucosa 
were thickened due to oedema but no increase in collagen fibres was seen. We did 
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observe the formation of fibrosis at later time points after irradiation. These later 
studies also elucidate whether the observed differences herald long term effects 
and are therefore of clinical importance, or represent only short term differences 
of reaction patterns. 
Conclusion 
In this study dose dependent radiation injury to the rectum was assessed with 
histopathological parameters. Several of these parameters especially ulceration, 
vascular occlusion and hyperplasia of the mucosa proved to be age dependent, but 
mostly not statistically significant. There might be a different age-related reaction 
pattern. Most differences between the two age groups were very subtle, 
supporting our hypothesis that there are no major differences in radiosensitivity 
with age. 
The relevance of the observed histological differences should be investigated 
with longer follow up. 
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Abstract 
Background and purpose: Radiation treatment of the elderly (> 75 years) is 
often modified due to an assumed decrease in tolerance of normal tissues in 
these patients. There are only few radiobiological data available on radiation 
toxicity as a function of age. Therefore histological studies on age-related 
radiation changes of the rectum were performed. In our previous study on early 
changes, discrete histopathological differences between the rectum of young 
and old Wi star rats were observed [17]. To investigate whether these differences 
herald long term effects which could be of clinical importance, studies with 
longer follow up periods have been carried out. 
Material and methods: The rectum of young and old female Wistar rats (12 and 
78 weeks respectively) was irradiated with single doses of 22 Gy and 39 Gy 
with a field size of 1.5 x 2.0 em. The animals were sacrified at 24 and 52 weeks 
after treatment. To evaluate radiation damage, 12 histological parameters were 
assessed in four areas of the rectum. A total radiation injury score was 
calculated. Furthermore, the number of endocrine cells in the different areas of 
the rectum was determined. Animals that died prematurely were also evaluated, 
provided autolysis did not interfer with the histology. 
Results: The Radiation Injury Score (RIS) appeared to be dose related at 24 
weeks but not at 52 weeks after treatment. An age related difference in the RIS 
was not observed. Most individual parameters did not show significant 
differences between young and old rats. However the incidence of mucosal 
ulceration and of vascular occlusion showed subtle differences, especially 
when the results of the previous studies with earlier time points were taken into 
consideration. In accordance with the previous study ulceration was not seen in 
the young rats after 22 Gy, while the older group occasionally showed 
ulceration. After 39 Gy, the incidence of ulceration was higher in the young 
animals. Vascular occlusion was present more often and more extensive in the 
older group. Moreover, the older rats showed a significant increase in the 
number of endocrine cells within and adjacent to the treatment field. We found 
a high incidence of radiation-induced tumors within the treated area (40 - 60 
%), but only after a dose of 22 Gy, and which was independent of age. 
Conclusions: Studies on early radiation induced changes of rat rectum showed 
subtle differences between young and old rats. Some of these changes were still 
observed at these later time points, but they did not seem to lead to significant 
differences in late effects. 
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Introduction 
Elderly patients fonn the maJonty of patients to be treated in most 
radiotherapy departments [1,23]. A further increase in the average age of cancer 
patients is expected for the next decades for demographic reasons due to 
improvement of general health care as well as the age-dependent incidence of 
most malignant tumors [4]. Radiotherapy with a curative intention is often 
modified in elderly patients, because of an assumed decrease in normal tissue 
tolerance in this age group. However, from clinical studies there is evidence that 
toxicity of radiation therapy depends on the functional status of the nonnal tissues 
that surround the tumor and not or very little on biological age [1,21,24]. More 
radiobiological data are needed regarding the influence of age on radiation 
sensitivity of normal tissues. This applies especially for radiation changes in the 
long tenn. 
Since the rectum is an important dose-limiting organ in radiotherapy of 
urogenital tumors, a histopathological study on rectal toxicity was carried out. For 
this purpose the rectum of young and older rats was irradiated and histological 
changes were studied in time to obtain detailed infonnation on the progression of 
rectal injury. The results of the early time points (up to 10 weeks after treatment) 
showed subtle histological differences between the rectum of young and old rats, 
especially ulceration was observed in a higher incidence in the older age group 
[17]. Severe vascular changes occurred relatively early and were more extensive 
in old rats. Furthennore, in the area adjacent to the treatment field, cell 
proliferation increased significantly in older animals at I week after 22 Gy, which 
did not occur in the young group. In the present study the long term effects of 
these rectal changes at 24 and 52 weeks after irradiation, have been evaluated. 
Materials and methods 
Laboratory animals 
Female Wistar rats, aged 12 and 78 weeks, were used (Harlam Zeist, the 
Netherlands). This allowed a follow up time of 52 weeks in the majority of 
animals. 
They were housed under conventional conditions with food and water ad 
libitum in light controlled rooms (light on at 06.00 h, off at 18.00 h). The 
experimental protocol was approved by the Animal Ethical Committee of the 
University of Rotterdam. Upon arrival the rats continued on their normal standard 
diet and were allowed to recover fully, as judged by a return of body weight 
towards that on arrival. Young rats weighed approximately 220 g, whereas the 
older animals had an average weight of 350 g at the time of irradiation. 
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Experimental design 
As described earlier, female rats of both age groups were irradiated with single 
doses of 22 Gy and 39 Gy [17]. These doses represent the LD20 and LDSO level, 
respectively. At 24 and 52 weeks after irradiation, at least 5 rats of each irradiated 
group were sacrified. To be able to evaluate a sufficient number of animals with 
complete follow up, more than 5 animals in each group were irradiated (See Table 
3-1). For each time point 3 non-irradiated rats of the same age, housed under the 
same conditions and sacrified simultaneously, served as controls. 
Irradiation procedure 
The method of anesthesia as well as the irradiation procedure have been described 
earlier [17]. Briefly, the animals were anesthesized with Ketamine [Parke -Davis] 
intraperitoneally and Xylazine 2 % [Bayer AG] subcutaneously. Irradiation of the 
rectum was performed with a Philips 250 RT Orthovolt X-ray machine, operated 
at 200 KV and 20 rnA. The dose rate at the level of the rectum was 1.36 Gy/min 
for the young animals and 1.25 Gy/min for the older rats, due to the difference in 
skin- rectum distance as a result of overlying fat tissue. A lead shielding for the 
head, thorax, upper abdomen and limbs was used during treatment. The field size 
was 1.5 x 2.0 cm, with the lower border above the orifices of vagina and urethra 
to avoid acute epithelial toxicity of these tissues. 
Quality control was performed with thermoluminiscency dosimetry catheters 
(TLD) in the rectum of 50% of randomly assigned animals. 
Histology 
The method of fixation and preparation for histology was described before. In 
short, the entire rectosigmoid (± 5 cm) was removed after sacrificing the animal, 
examined macroscopically and fixed in 3.7 % formalin for a maximum of 24 
hours. The specimen was sliced transversely in four pieces of 0.4 cm each, i.e. a) 
between the anus and the irradiated area (0 - 0.4 cm), b) caudal part of the 
irradiated area (O.S - 1.2 cm), c) cranial part of the irradiated area (1.2 - 1.6 cm) 
and d) above the irradiated area (3.1 - 3.5 cm). Three of these slices were marked 
with different colours of dye for the recognition of the location of the rectum. The 
four slices of the rectum were embedded in one block. The specimens were 
routinely processed and embedded in paraffin. Sections were cut 5 f.Im thick and 
stained with hematoxylin-eosin (HE), periodic acid Schiff plus reagent (PAS+), 
Sirius red (SR) and resorcin fuchsin (RF) according to standard methods. 
Immunohistochemistry 
For immunohistochemical studies, antibodies recognizing the following antigens 
were applied: smooth muscle actin (SMA) [Biogenex], Collagen III (Coli III) 
[Biogenex], neurofilaments (NF) [Dako], S-IOO protein [Dako], Cytokeratin 
[NeoMarkers] and serotonin [according to de Bruine e.a. [2] ]. 
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Sections, 4 J.lm thick were reacted with appropriate dilutions of antibodies 
after blocking with H20 2 and antigen retrieval with citric acid. Antigens were 
visualised using a streptavidin-biotin peroxidase conjugate system [Biogenexl. 
Scoring system for rectal injury 
A semiquantitative histopathological radiation damage score appropriate for 
this experimental setting was developed, based on the Radiation Injury Score 
introduced by Hauer-Jensen and co-workers [10], for the assessment of radiation 
injury. Parameters were chosen in order to be able to score them present or absent, 
for their representation of changes in the different layers of the colon wall 
(mucosa, submucosa, muscularis), as well as for their representation of acute and 
chronic injury. The various parameters as changes of epithelial cells, crypt 
distortion, discontinous muscular mucosae, mucosal ulceration, squamous 
metaplasia, hyperplasia, colitis glandularis cystica profunda and carcinoma were 
scored present when observed in either part of the section. In cases with severe 
ulceration, crypts were absent and distortion was not assessed. Parameters as 
hyalinization of blood vessel walls and occlusion of blood vessels were scored 
present when observed in one or more of the blood vessels of the section. 
Furthermore the lumen of the rectum was scored normal if star shaped and 
abnormal if circular shaped. The thickness of the submucosa was scored normal 
or broadened in relation to the submucosa of the non-irradiated part of the rectum. 
For the radiation injury score (RIS) the scores of the above mentioned 12 
parameters were summated. 
For each animal these parameters were scored in all four pieces of the rectum. 
Within the treatment field, a parameter was considered to be present when 
observed in at least one of the two slices of the radiation field. To describe the 
extent of the radiation-induced changes, the presence of a parameter in both of the 
sections of the treatment field was evaluated separately. 
All sections were evaluated by two investigators independently (MJJ. 0.-
v.A. and M.L.F. v.V.) without access to the treatment code. Discrepancies were 
discussed and the final score was determined by consensus. 
Of all animals who died prematurely, due to toxicity or other causes, the 
latency time was analysed. Histology was performed on the rectum of these rats, 
except for those with too much autolysis (see Table 3-1). 
Endocrine cells were counted as the number of serotonin positive cells in 20 
randomly selected crypts in each of the four sections. The cell counts obtained by 
the two investigators were averaged. The mean of the two sections of the 
treatment field was calculated. 
Data analysis 
The incidence of each histopathological parameter in all sections was calculated 
separately for each age group and for each time point. Within the treatment field 
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incidences were calculated for presence in either one of the sections and 
separately for presence in both sections. A summation of all present parameters 
was calculated for each animal to obtain a quantitative injury score for the 
sections within the treatment field as well as for the sections above and below the 
field. Per group of animals the mean of the injury score (± sem) was calculated 
according to age, dose and time point. 
Statistical comparison of data was performed with a logistic regression 
analysis for each histological parameter separately; for this purpose the data of the 
2 time points were pooled together. The histological features were the dependent 
variables and radiation dose and age were independent variables. The total injury 
score and the number of endocrine cells were compared by the analysis of 
variance test (ANOV A; single factor), using the MS Excell 97 program. In all 
cases, a significance level of 5 % (two sided) was used. 
Results 
Dosimetry with liD-measurements showed on average a small difference of 
minus 3 % (SD ±1.0) between measured and planned dose, irrespective of dose 
and age group. 
Control animals did not show any histopathological alteration at either of the 
two time points (injury score was 0), except for one animal of 78 weeks that died 
inexplicably after 30 weeks. Histology of this rat showed severe autolysis; the 
animal was excluded from analysis. 
In Table 3-1 the total number of irradiated animals in each group is shown as 
well as the numbers with a follow up completed according to plan and those with 
premature death. There was no significant difference in premature death between 
young and old rats. Of all 46 animals that died prematurely, 21 (46 %) could not 
be evaluated with histology due to autolysis. Of the remaining 25 animals (54 %) 
with premature death, 2 rats died of urogenital complications. All the other rats 
died due to rectal complications and/or secundary tumors within the irradiated 
area. Of these 25 animals, 17 (68 %) developed a macroscopic megacolon and 
only 2 (8 %) of these rats had fistulas to the uterus at the time of obduction. 
38 
Effect of age 0/1 late radiation changes of the rectum 
Table 3-1. 
Total number of irradiated animals in relation to age, dose and follow up period, number of 
animals with complete follow up and number of animals with premature death, with or 
without histological evaluation of the rectum. 
Age (wks)! Tot. num. Num. With Num. Num. 
Dose (Gy)! irradiated complete premature premature 
Follow up period (wks) follow up (%) death with death without 
histoI. data histol. data 
(%) (%) 
12 wks 122 Gy/24 wks 6 5 (83 %) 0(0 %) 1(17%) 
12 wks/39 Gy/24 wks 26 9 (35 %) 9 (35 %) 8 (30 %) 
12 wks/22 Gyl 52 wks 6 5 (83 %) 0(0 %) 1(17%) 
12 wksl 39 Gyl 52 wks 15 6 (40 %) 4 (27 %) 5 (33 %) 
78 wks/22 Gyl 24 wks 6 5 (83 %) 0(0%) 1(17%) 
78 wks! 39 Gyl 24 wks 15 9 (60 %) 3 (20 %) 3 (20 %) 
78 wks! 22 Gy! 52 wks 9 5 (56 %) 3 (33 %) I (II %) 
78 wksl 39 Gyl 52 wks II 4 (36 %) 6 (55 %) 1(9 %) 
The mean latency time of all animals with premature death was on average 14 
weeks as is shown in Table 2, except for the older group after a dose of 22 Gy. 
They showed a longer latency time of 31.6 ± 12.7 weeks, probably due to the fact 
that in this group 80 % died of a malignant tumor within the treatment field, some 
with metastasis, instead of rectal complications. 
Of the 48 animals with complete follow up, only 3 (6 %) had a macroscopic 
megacolon and 7 ( 15 %) rats had a fistula to the uterus at the time of obduction. 
Remarkably, of all animals with a fistula only one belonged to the older group. 
Most of the surviving animals did not show any macroscopic changes. 
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Table 3-2. 
Mean latency time in weeks with standard deviation of the animals who died prematurely in 
relation to age and dose, irrespective of planned follow up period. 
Age (wks)! 
Dose (Gy) 
12 wks!22 Gy 
12 wks!39 Gy 
78 wks!22 Gy 
78 wks!39 Gy 
Number of animals with 
premature death 
2 
26 
5 
13 
Mean latency time ± SD 
(wks) 
16 ± 9.9 
11.2±7.1 
31.6±12.7 
lS.S±7.3 
The incidences of all parameters. within one or more of the sections of the 
irradiated rectum at the different time points after treatment are shown in Table 3-
3 for all animals examined histologically. All histological changes were observed 
within the treated area only. except for hyperplasia. which was observed proximal 
of the treatment field and occasionally at the cranial side within the field. 
As shown in Table 3-3 an abnormal shape of the lumen of the rectum, mainly 
circular instead of star-shaped, frequently occurred after the high dose and in rats 
with premature death without significant differences between young and old rats. 
After 39 Gy epithelial changes, flattening and multilayering of epithelial cells, 
occurred frequently in both age groups at both time points. After a dose of 22 Gy, 
changes of epithelial cells were observed only in the old group (this difference 
was not significant). 
Mucosal ulceration was mainly found after 39 Gy, in both age groups at 24 
weeks and in the young group also at 52 weeks after treatment, but usually not 
around the whole circumference and often in one of the two sections only. No 
significant difference between the age groups could be found. Analysis of 
ulceration for all time points summated, including the previously published data 
of \, 2 ,4 and \0 weeks after treatment [17], also showed no significant age-
related differences. As shown in Table 3-3, ulceration was observed more 
frequently in both age groups of those animals that died prematurely compared 
with the groups of surviving rats. Furthermore, in animals with premature death, it 
concerned ulceration of the whole circumference of both sections in 70 - 90%. 
Irregular crypts repopulated with normal epithelial cells (crypt distortion) 
were observed very frequently at 24 as well as 52 weeks after irradiation in both 
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age groups, as is shown in Table 3-3, Crypt distortion in one or both of the 
sections within the treatment field was observed in nearly all animals after a dose 
of 22 Gy at both time points, regardless of age. After 39 Gy, crypt distortion was 
observed less frequently due to the high incidence of ulceration. 
Table 3-3. 
Incidence of various histological parameters (percentage) in the rectum of young and old rats 
within the treatment field as well as hyperplasia in and/or rostral of the irradiated field, in 
relation to dose at 24 and 52 weeks after treatment (RT) or at moment of premature death. 
(Y = Young, 0 = Old. 22 = 22 Oy, 39 = 39 Oy). 
Histologic Follow up 24 weeks Follow up 52 weeks Premature death 
parameter 
Y/22 0/22 Y/39 0/39 Y/22 0/22 Y/39 0/39 0/22 Y/39 0/39 
Abu. 
Shape of 0 0 89 89 20 60 66 75 66 92 89 
lumen 
Epithelial 0 20 66 66 0 60 50 75 66 85 67 
changes 
Mucosal 0 0 56 56 0 20 50 0 66 92 78 
ulceration 
Crypt- 100 80 78 44 100 100 66 100 66 30 33 Distortion 
Discont. 0 0 89 67 40 40 66 75 66 85 67 Musc.muc. 
Squamous 0 0 33 11 0 0 33 0 0 15 0 
metaplasia 
Hyperpl. 0 0 0 11 0 0 17 0 0 62 44 
Hyalinosis 100 80 89 100 80 100 83 100 100 92 89 
Occlusion 20 60 56 78 0 40 50 75 33 77 89 
Increase 100 100 44 78 80 60 17 25 66 23 33 
of collagen 
Colitis gl. 0 0 44 11 0 0 33 25 0 15 22 Cyst. Prof. 
Malign. 0 0 11 11 60 40 0 0 66 0 0 Tumors 
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A discontinuous muscularis mucosae, replaced by collagen or inflammatory 
infiltration occurred more frequently after 39 Gy than after a dose of 22 Gy, again 
without significant differences between the rats of both ages, Also in the animals 
with premature death, a discontinuous muscularis mucosae was observed in 67 -
85 % of the animals without significant differences between the age groups. 
Squamous metaplasia of columnar epithelium was seen after a dose of 39 Gy 
only and more frequently in the young animals at both time points (difference for 
both time points summated not significant). 
Hyperplasia rostral of the irradiation area was also observed, but only after a 
dose of 39 Gy. However, in the rats with premature death, the incidence of 
hyperplasia was significantly higher (0 -17 % vs 44 - 62 %, p = 0.05) (Table 3-
3). The presence of this parameter frequently corresponded with the macroscopic 
observation of a megacolon and occasionally with ulceration. Of all the young 
animals with hyperplasia, 89 % developed a megacolon and in the older group, all 
rats with hyperplasia developed a megacolon. 
Thickening of blood vessel walls by hyalinization resulting in stenosis of the 
lumen was observed very frequently (80 - 100 %) after both dose levels at both 
time points i.e. 24 and 52 weeks without significant differences between the age 
groups. When hyalinosis was observed at 24 weeks, it appeared to be present in 
both slices of the radiation field in 50 % of the animals, regardless of dose and 
age. At 52 weeks, in approximately all animals with hyalinosis it was observed in 
both slices. 
In cases of extreme hyalinization, complete occlusion of one or more of the 
blood vessels in the section could occur. After a dose of 22 Gy occlusion of blood 
vessels occurred more often in the older animals (difference for both time points 
summated not significant). After 39 Gy, the incidence of vessel occlusion was 
even higher in both age groups. This also applied for the animals who died 
prematurely. Extensive occlusion of blood vessel walls (observed in both slices of 
the irradiated area) was observed in 50 - 60 % of the old animals, in contrast to 
the young group where extensive occlusion was observed in only 0 - 20 % 
(difference significant for both time points after treatment; p = 0.05). 
An increase in thickness of the submucosa due to collagen accumulation was 
observed in the irradiated rectum very frequently (incidence 60 - 100 %) after 22 
Gy in both age groups in comparison with unirradiated rectum and with control 
animals. After the higher dose, especially at 52 weeks and in animals with 
premature death, an increase in thickness of the collagen occurred less frequently 
(17 - 33 %). In these animals a change in the density of the collagen flbres of the 
submucosa was seen with more space between the fibres; 0 - 33 % at 52 weeks 
after 39 Gy, 50 - 78 % for rats who died prematurely. This change in density of 
the collagen fibres strongly correlated with mucosal ulceration and was 
independent of age. 
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As long as the rectum wall was not destroyed due to ulceration, ganglion cells 
were evenly distributed in each slide in all animals. Proliferation of 
neurofilaments was not observed. 
At 24 as well as 52 weeks after treatment and in the animals with premature 
death, colitis glandularis cystica profunda was seen after a dose of 39 Gy only (II 
- 44 %), without significant differences between age groups (Table 3-3). 
Malignant tumors within the irradiation area most frequently occurred after a 
dose of 22 Gy at a follow up time of 52 weeks (40 - 60 %) and in the rats with 
premature death after 22 Gy (66 %). These tumors involved adenocarcinomas (85 
%) and squamous cell carcinomas (15 %) (Table 3-3). 
Total radiation injury score 
In Table 3-4 the mean summation of all parameters for the radiation injury score 
(RIS) is presented for the various groups including rats with premature death. The 
mean summation appeared to be dose related for both young and old animals at 24 
weeks (p- value 0.005 and 0.03 respectively). At 52 weeks after treatment there 
was no significant relationship between RIS and dose for both age groups. 
For the two age groups there were no significant differences between the RIS 
at any time point. 
Table 3-4. 
Mean summation (± sern) of present parameters of radiation injury of the rectum for animals 
with complete follow up as well as for animals with premature death. Presented per age- and 
dose group. 
Young Old Young Old 
22Gy 22Gy 39Gy 39Gy 
Follow up 24 wks 3.2 ± 0.2 3.4 ± 0.7 6.6 ± 0.7 6.3 ± 0.8 
Follow up 52 wks 4.0 ± 0.6 5.4 ± 1.3 5.3 ± 1.5 S.S ± 0.7 
Premature death 6.0 ± 1.5 6.8 ± 0.5 6.1 ± 0.6 
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Number of endocrine cells 
The mean numbers of endocrine cells per 20 crypts in the different areas of the 
rectum at 24 weeks after treatment are shown in Figure 3-1. In comparison with 
control animals, the younger group showed some increase in endocrine cells, 
above the treatment field, which was not significant (p = 0.06). In the older group 
however, an increase in endocrine cells was observed within the treatment field 
after 22 Gy as well as 39 Gy (p = 0.008 and p = 0.02 respectively). Furthermore, 
the number of endocrine cells in the adjacent unirradiated parts of the rectum was 
also increased significantly in the older group in comparison with the control 
animals. For the caudal area between anus and irradiation field this increase was 
distinct in the low and high dose group (p- value 0.06 and 0.02 respectively). 
Above the treatment field the endocrine cells also increased, but not significantly. 
This phenomenon was not observed in the young animals. 
In Figure 3-2 the mean number of endocrine cells within the different parts of 
the rectum is shown for the follow up of 52 weeks. The control animals in the two 
age groups showed no differences in endocrine cells. In the younger animals no 
significant changes in endocrine cells were observed in comparison with control 
animals, irrespective of dose and location in the rectum. In the low dose group 
however the older animals not only showed an increase in endocrine cells within 
the treatment area, but also above the irradiated rectum (both p-values = 0.02). 
The number of endocrine cells after 39 Gy was assessed, but due to extensive 
ulceration which did not permit evaluation of enough crypts, these values were 
based on fewer data. No significant differences were seen compared with control 
values. 
For the animals who died prematurely the mean number of endocrine cells 
after a dose of 39 Gy were not significantly different from control values. These 
data were based on few observations due to a large number of animals with severe 
and extensive ulceration. 
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Figure 3~1 
Mean number of 
endocrine cells per 
20 crypts in the 
rectum of young and 
old rats at 24 weeks 
after treatment as a 
function of dose and 
in relation to the 
position in the 
treatment field. Error 
bars indicate 
standard deviations 
(Y = young animals, 
o = old anim111s; 
o = control group, 22 
= 22 G.\', 
39 = 39 Gy). 
Figure 3~2 
Mean number of 
endocrine cells per 
20 CI)pts in the 
rectum of young and 
old animals at 52 
weeks after 
irradiation as a 
junction of dose and 
in relation to the 
position in the 
treatment field. Error 
bars indicate 
standard deviations 
(Y = young animals, 
o = old animals; 
0= control group, 22 
= 22 G.\', 
39 = 39 Gy) 
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Discussion 
In cancer treatment of the elderly, many physicians tend to perform pretreatment 
selection. In radiation therapy the assumption that normal tissue tolerance 
decreases with increasing age is the basis for undertreatment in elderly patients. 
Recent clinical studies on this subject strongly support the idea that acute as well 
as late tissue toxicity in patients older than 74 years is not increased compared 
with younger patients [21,22,24,27]. Experimental data on this subject generally 
address the influence of age on acute radiation induced changes. Most of these 
animal studies deal with skin reactions and do not indicate an increase of 
radiosensitivity with older age [6,14,16]. Despite the fact that the rectum is an 
important dose limiting organ in radiotherapy in pelvic malignancies, and 
radiation induced complications of the rectum are frequently described 
[3,7,8,9,10,19], studies on radiosensitivity of the rectum in relation with age are 
rare. In previous experiments with single doses of irradiation it appeared that there 
was no significant difference in the incidence of rectal stenosis resulting in a 
megacolon between young and older rats, using clinical and radiological 
endpoints [18]. The latency period for the development of rectal stenosis was 
11.6 ± 6.2 weeks after irradiation in young rats and 15.0 ± 3.9 weeks in older 
animals, which corresponds with the results of the present study. To study 
differences in reaction patterns between young (12 weeks) and older female 
Wistar rats (78 weeks) over a longer period of time, rectal tissue was examined 
histologically 24 and 52 weeks after irradiation. Two radiation doses equivalent to 
the LD20 ( 22 Gy) and LD80 (39 Gy) were applied. In our previous studies with 
follow up points of 1, 2, 4 and 10 weeks after treatment [17], some subtle age 
related histological differences were observed. 
From our studies with early and late time points it can be deducted that 
ulceration apparently is reversible in some cases. The high incidences of 60 - 100 
% for mucosal ulceration at 2, 4 and 10 weeks after 39 Gy and the lower 
incidence of 0 - 50 % observed after 52 weeks seem to indicate this. According to 
Trott e.a. [25,26] healing of a lesion can occur if no additional damage interferes, 
but healing of a manifest ulcer cannot restitute the original tissue structure, but 
leads to defective healing with scar formation, dystopic epithelial proliferation and 
thrombosed vessels. Vascular occlusions might disturb the regenerative capacity 
of the mucosa. If not self-limiting, chronic irradiation enteritis has been described 
by Oya e.a. as a slowly progressive disease [19]. Late cases of chronic irradiation 
enteritis showed ulcerative stricture type properties with tissue degradation, such 
as fistulas, perforation and dysplastic epithelia. These findings are in accordance 
with our studies where we found either progressive disease (ulceration, fistulas, 
megacolon or malignancies) or healing with scar lesions (cryptdistortion, vascular 
hyalinosis and occlusion of blood vessels). 
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In our studies with early time points severe vascular changes occurred earlier 
(4 weeks) and were more extensive in older animals than in the younger group 
(10 weeks). In the present study, again vascular occlusions were observed more 
often in older rats after both doses at 24 as well as 52 weeks after treatment. 
Despite the significant higher incidence of severe vascular changes in older rats, 
there was no higher incidence of premature death or severe ulceration in the older 
group, The significant increase in cell proliferation in the areas adjacent to the 
irradiated field, as was found the first week after treatment [17], might be an 
important factor in the healing of initial ulceration. 
We found a high incidence of radiation-induced tumors within the treated area 
in both age groups (40 -66 %). Remarkably these tumors occurred in the group of 
animals after a dose of 22 Gy only. The fact that tumors were observed after the 
lowest dose seems in contrast with clinical literature [5,11,15]. In studies on long 
term effects after radiotherapy for Hodgkin's disease as well as investigations 
among atomic bomb survivors, the incidence of secundary tumors increased with 
dose. An important difference is, that the highest dose in the clinical studies was 
fractionated and lower in comparison with single doses used in our studies. In 
most clinical studies, the incidence of secundary tumors is higher for patients in 
their adolescence or young adulthood at the time of treatment [5,12,15]. We did 
not find a difference in tumor incidence between the age groups. Possibly the 
incidence of tumors in our young group might be higher with longer follow up 
periods. 
Total rectal damage was expressed in the total radiation injury score (RIS). At 
24 weeks after irradiation there was a clear dose dependency, but no significant 
difference with age. At 52 weeks this dose dependency disappeared, although the 
RIS remained high. This suggested that some of the parameters involved became 
manifest at a late stage. This is certainly true for the young rats after 22 Gy, where 
the RIS gradually increased from ~ 1 (week 1) to ~ 3 (week 10) [17], followed by 
a further, but small increase to 4 at week 52. After 39 Gy, already at 2 weeks, the 
RIS increased to 4.5, which remained ~ 5-6 throughout the follow up period. In 
contrast, for the old rats the majority of parameters involved was seen already at 4 
weeks after treatment with a RIS of 4-5.5, while this was ~ 2 for week 1 and 2 
[17]. This RIS remained high for the longer follow up periods, irrespective of 
dose. These data do support the hypothesis that late rectal damage is a 
consequential event of acute rectal damage. This would suggest that intervention in 
and amelioration of rectal damage should occur shortly after radiation for the old 
animals. 
Hyperplasia of endocrine cells in the intestines has been noted in cases of 
celiac disease, chronic ulcerative colitis and chronic radiation enteritis [2,20], all 
characterized by chronic mucosal damage and ensuing regeneration. The cause of 
endocrine cell hyperplasia under the latter circumstances is not clear, but might be 
related to increased cell turnover or decreased maturation. De Eruine e.a. have 
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described the renewel and hyperplasia of endocrine cells by combination of self-
replication and recruitment from primitive precursor cells [2]. There appeared to 
be two subpopulations of endocrine cells, a rapidly renewing fraction with a 
turnover time of approximately 16 days and a relatively slowly proliferating 
fraction which renewed in about 150 days, The slower renewing cells were evenly 
distributed over the crypts, were less exposed to cell loss during migration and 
represented therefore a more static resident population. We therefore assessed the 
number of endocrine cells in the crypts at these late time points in order to study 
radiation-related hyperplasia of these cells in the two age groups. The number of 
endocrine cells in the rectum of the older rats increased significantly within the 
treated area as well as on the caudal side at 24 weeks after both dose levels. 
However at 52 weeks, only the number of endocrine cells above the irradiation 
field of the older animals increased significantly. In our earlier studies [17], we 
observed an increase of proliferative cells at the first week after radiotherapy in 
these older rats. Therefore, the increased number of endocrine cells at the late time 
points might reflect this earlier proliferation activity since it has been suggested 
that enteroendocrine cells are a non specific result of cell proliferation [2]. 
Increase in thickness of the collagen of the submucosa was observed in the 
course of this study, especially after 22 Gy, which has also been described by 
others [13]. No significant differences between the age groups were found. 
However, after 39 Gy only a small proportion of the animals showed increased 
collagen thickening in the submucosa, which was evident particularly after 52 
weeks (17-25 %). The fact that after 39 Gy a large number of animals did not 
develop collagen thickening in the submucosa coincided with the presence of 
mucosal ulceration. This ulceration actually masked the process of collagen 
thickening which gave the appearance of loose collagen fibres and hence a 
reduction in density. 
The observed differences between the age groups for early changes of rat 
rectum, did not seem to lead to major differences in long term effects. Therefore, 
although early reaction patterns showed little differences between young and old 
rats, clinical outcome in the long term seemed to be similar. Based on these 
experimental studies, the assumption that the radiation tolerance of rectal tissue 
has diminished with older age cannot be justified. Since more clinical data are 
needed, we strongly support inclusion of older patients in clinical trials. 
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Conclusion 
In this study dose dependent late radiation injury to the rectum was assessed with 
histopathological parameters. Several of these parameters especially vascular 
occlusion proved to be age dependent, but most of them not significantly. The 
significant differences between age groups were observed much earlier in the 
acute phase of tissue reactions. Major changes in ulceration and vasculature were 
not observed with longer follow up. Based on these experimental studies on 
radiation tolerance of rectal tissue, modifications in dose fractionation schedules 
for pelvic radiotherapy cannot be justified solely for reasons of old age. 
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Abstract 
Purpose: To establish a reference planning target volume for postoperative 
radiotherapy in stage Ib and IIa N + cervical carcinoma, based on 47 
lymphangiograms and 15 CT -scans. 
Methods: Radiation oncologists (n=17) from all radiotherapy institutes in The 
Netherlands were asked to define the clinical target volume (CTV) and planning 
target volume (PTV), and to delineate (on simulation films) the radiotherapy 
treatment portals following a radical hysterectomy with lymph node dissection 
for an early stage cervical carcinoma with positive iliac lymph nodes. A 
reference PTV was defined by using 47 normal lymphangiograms and CT -data 
of the pelvis from 15 patients who underwent surgery for cervical carcinoma. 
The simulation films were digitized and evaluated for adequacy in covering the 
PTV, previously individually determined by the radiation oncologists. 
Subsequently, the simulation films were also evaluated for adequacy in 
covering the reference PTV. 
Results: Large variations were observed in the portals used and in treatment 
techniques. From the digitized films, it appeared that in 50% of the cases the 
defined PTV was not covered adequately. Furthermore, 71 % of the treatment 
plans would not cover the lateral borders of the reference PTV sufficiently. 
Conclusions: There appears to be no consensus on the target volumes to be 
irradiated in postoperative radiotherapy of early stage cervical carcinoma. When 
a PTV defined on the basis of lymphangiograms and CT-data is taken as a 
reference, 71 % of the treatment plans would not cover this PTV adequately. 
These findings indicate the need for a consensus in the design of standardized 
treatment volumes. 
54 
Reference PTV in cervical carcinoma stage IB-llA 
Introduction 
Patients with squamous cell carcinoma of the uterine cervix FIGO stage Ib and 
IIa are often treated by a radical hysterectomy and an iliac lymph node 
dissection. In case of histologically proven lymph node metastases it has been 
shown that the 5-year overall survival rate increases by adding postoperative 
radiotherapy to the pelvis (43%-63%) [8]. The treatment volumes vary among 
institutions; most agree upon including the iliac and obturator lymph nodes 
[1,3,7,9,14,16,21,23,24]. some even add the para-aortic region to the target 
volume [6,15,22]. The prescribed dose to the pelvis generally varies between 45 
Gy and 50 Gy [2,9]. 
The complication rates for small bowel or bladder are reported to range 
from 3% to 24%, and 3% to 8%, respectively [2]. In fact, these complications 
are dose limiting in this type of patients [8,17]. To reduce the volume and dose 
of irradiated small bowel and bladder, conformal radiation therapy has been 
suggested. The preamble to this high-precision radiotherapy is the need for a 
correct and reproducible definition of the target volume. 
In this study, the variations in clinical target volumes and radiation 
techniques of all Dutch radiotherapy institutes were assessed [18]. All 
simulation films with the target volumes drawn in by the participating radiation 
oncologists were digitized and compared with the CT-scan of a particular 
patient, with the tumour region and lymph nodal chains identified. To verify the 
position of the target structures, a reference target volume for the primary 
tumour region and the involved lymph nodal chains was defined. This reference 
target volume was structured on 47 Iymphangiograms and 15 CT-scans. Finally, 
the treated volumes indicated by the radiation oncologists were compared with 
the reference target volume. 
Materials and Methods 
In this study, a theoretical patient is presented with a squamous cell carcinoma 
of the cervix FIGO stage Ib or IIa who underwent a radical hysterectomy with 
an iliac lymph node dissection. Histological examination showed radical 
removal of the cervical tumour and parametria, with lymphatic invasion. In the 
specimen 34 lymph nodes were identified with two positive lymph nodes in the 
distal iliac region on the left and one near the common iliac artery on the right. 
All Dutch radiotherapy institutes were asked to take part in the study. A 
case history and anterior and lateral simulation films were sent to the 
participating radiation oncologists. They also received four body contours (CT-
slices enlarged to real size) of the 'study patient' at different levels, i.e. at the 
level of the parametria, the sacral promontory, the para-aortic region (level 
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vertebra lumbar 2) and the obturator region. Treatment portals were outlined on 
the anterior and lateral simulation films. The participants defined the clinical 
target volume (CTV) and outlined the planning target volume (PTV) on the 
pelvic contours. The radiation oncologists individually determined patient 
positioning, radiation technique and beam energy based on institutional policy 
(see Appendix I). 
Treatment portals and beam data of each institute were imported in a 3-D 
treatment planning system (CADPLAN Varian-Dosetek, Finland). Dose 
distributions were computed using the defined PTVs, with beam data of a 10 or 
25 MV photon beam. 
The calculated treatment plans and the arrived treatment volumes were 
compared with the PTV description of the radiation oncologists of the different 
institutions. A margin of at least 5 mm between PTV and field border was 
considered adequate. 
To arrive at a correct definition of the PTV for postoperative irradiation for 
early stage node-positive cervical cancer, also a reference PTV was established. 
In this reference PTV the primary tumour region, the proximal one-third of the 
vagina, and the obturator, iliac and para-aortic lymph nodes were included. In 
this reference PTV the para-aortic region was included, although only a small 
part of the participants considered the para-aortic lymph nodes as part of the 
CTV. The precise location of the para-aortic and common iliac lymph nodal 
chains was defined using 47 normal lymphangiograms of females without 
pathological findings in the iliac and para-aortic regions. When the internal iliac 
lymph nodes were visible, they were identified too. The lymphangiograms were 
digitized on the anterior-posterior (AP) films. For comparison purpose, four 
bony landmarks were chosen, i.e. the upper border of the acetabulum, left and 
right, the upper border of vertebra lumbar 2 and the center of the symphysis. 
Subsequently, the digitized lymphangiograms were scaled and positioned 
relative to the bony structures on the AP simulation film of the study patient 
after being corrected for length, width and rotation of the pelvic bones (Fig. 4-
1 ). 
Computer tomography data of the pelvis from 15 female patients who had 
surgery for early stage cervical carcinoma were used to define the obturator 
lymph nodes, the internal iliac lymph nodes and the primary tumour region with 
the extent of the parametria to the lateral pelvic wall. The regions of interest 
were delineated on these CT -scan slices, i.e. the primary tumour region from the 
level of the diaphragm onto the vagina, and the para-aortic, iliac and obturator 
lymph nodes. The lateral extension of the parametria was defined by the fascia 
of the obturator internus muscle on the sidewall of the pelvic bones; this fascia 
is the surgical resection level of a Wertheim's hysterectomy. In order to obtain a 
contour of the defined CTVs, Beam's Eye View data were generated, digitized 
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and scaled to the bony structures of the study patient, in the same manner as 
with the lymphangiograms. 
Figure 4-1 
Scaling of 
lymphangiograms. 
Solid line: original 
contour from 
lymphangiogram; 
dashed-dotted line: 
rotated to get a 
horizo11lal position 
of the pelvis; dotted 
line: the axis 
through the spine is 
sLanting to make the 
same angle with the 
horizontal axis as 
for the reference 
patient; dashed line: 
conformed to length 
and width of the 
same axis in the 
reference patient at 
isocentre level. 
Figure 4-2 
Line enclosing 90% of 
Iymphangiograms. 
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We assumed the line enclosing 90% of the lymphangiograms (Fig. 4-2) and 
the CTV s of primary tumour and parametria based on the CT -scans to represent 
the reference CTV. To analyse the accuracy of this method, this procedure was 
also carried out with two randomly divided groups of half of the patients; the 
difference between these two groups appeared to be less than 3 mm. The 
reference PTV consisted of this reference CTV with a 10 mm margin added 
(Fig. 4-3). 
Finally, all treatment portals defined by the participating radiation 
oncologists were compared with the reference PTV. The margins between PTV 
and field borders were measured. A margin of at least 5 mm was considered 
adequate. 
Results 
Of the 18 institutes that were asked to participate, 17 responded (94%). There 
seemed to be a large variation in the description of the CTV and techniques 
used. There appeared to be three different CTV definitions: 
CTV type 1 consisted of the primary tumor, the proximal one-third part of 
the vagina, the obturator and iliac lymph nodes, and the para-aortic lymph node 
chain (5 x). 
CTV type 2 was similar to CTV I except for the para-aortic lymph nodal 
chain, with the upper border at the level of the aorta bifurcation (5 x). 
CTV type 3 consisted of CTV 2 with the iliac lymph nodal region ending 
just above the lymph nodes at the level of the common iliac artery (7 x). 
Five of 17 (29%) radiation oncologists considered the para-aortic lymph 
nodes part of the CTV, whereas 12 out of 17 (71 %) would only irradiate the 
pelvis. Besides the large variations in shape and size of the treatment portals 
used (Fig. 4-4), there were differences in the treatment technique. Seven 
institutes proposed to use parallel opposed anterior-posterior fields, nine 
institutes a four-field box technique and one institute a three-field technique 
(two lateral fields and a posterior field). 
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Figure 4-3 
Reference PTV. 
Figure 4-4 
Variations in 
treatment portals 
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For all treatment plans the margins were measured between the delineated 
PTV in the pelvic contours and the field borders of the treatment portals used, 
Le, at the level of the parametria and the para-aortic region. Results are shown 
in Table 4-1. At the level of the parametria 50% of all institutes had defined a 
margin of less than 5 mm, and 17% had defined no margin at all. At the level of 
the para-aortic region these percentages were 60% and 20%, respectively. The 
largest difference between PTV and field borders was measured at the level of 
the parametria: the PTV extended more than 20 mm outside the field borders. 
Table 4-1. 
PTV margins by the radiation oncologists to their own field borders, measured in mm 
Parametria 
Para-aortic lymph 
nodes 
>5 mrn 0-5 mm -5 - 0 mm <-5mm 
6/12 (50 %) 4112 (33 %) 0112 (0 %) 2112 (17 %) 
2/5 (40%) 2/5 (40%) 115 (20%) 0/5 (0%) 
The same measurements were carried out with the defined reference PTV 
and the field borders (Table 4-2). That is, at the level of the parametria 71 % of 
the institutes had defined a margin of less than 5 mm, and 59% had defined no 
margin. In the para-aortic region none of the institutes had defined a margin> 5 
mm, particularly on the left side of the para-aortic lymph nodal chain, where the 
lymph nodes are located more laterally at the renal hilus, as can be seen on the 
lymphangiograms. 
Table 4-2. 
Reference PTV margins (based on lymphangiograms and CT-scans) to the field borders by 
the radiation oncologists. 
Parametria 
Para-aortic lymph 
nodes 
60 
>5mm 0- 5 mm -5 - 0 mm < -5 mm 
5117 (29%) 2117 (12%) 0117 (0%) 10/17 (59%) 
0/5 (0%) 2/5 (40%) 1/5 (20%) 2/5 (40%) 
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Discussion 
In this multi-institutional study a definition and validation of the CTV for 
postoperative radiotherapy in early stage node-positive cervical cancer was 
obtained. Descriptions of the CTV and treatment plans for this type of radiation 
treatment were obtained from all Dutch radiation oncology centres [18]. There 
appeared to be no uniformity in the description of the CTV, as a result of which 
a reference CTV and PTV were defined based on 47 lymphangiograms and 15 
CT -scans. The defined reference PTV included all regions that were considered 
part of the PTV, as described by the participating radiation oncologists. The in 
this manner obtained reference PTV was compared with the description of this 
target volume as defined in standard textbooks. Based on these descriptions and 
the fact that there is a very small risk of involvement of the pre-sacral lymph 
nodes [4], they were not considered as part of the target volume. The reference 
PTV was compared with the treatment portals delineated by the radiation 
oncologists. 
Large variations in applied treatment portals were found. Part of the 
differences was due to variations in the CTV definition. There appeared to be 
three different CTV definitions, the first consisting of the primary tumour and 
parametria, part of the vagina, the obturator and iliac lymph nodes and the para-
aortic lymph nodal chain. The second definition was similar, except for the 
para-aortic lymph nodal chain, and the third comprised the smallest CTV with 
the iliac lymph node region ending just above the lymph nodes at the level of 
the common iliac artery. 
Apparently, five out of 17 radiation oncologists (29%) included the para-
aortic lymph nodes in the CTV. Of the remaining 12 radiation oncologists, five 
included the iliac lymph nodal chain up to the level of the aorta bifurcation and 
seven intended to irradiate the lymph nodes onto the level of the common iliac 
artery. 
Besides three different CTV definitions, there were also major variations in 
the shape and size of the treatment portals used within these three groups. This 
is probably due to some uncertainty as to the correct location of the primary 
tumour and the lymph nodal chains. Furthermore, a significant number of the 
oncology centres have 'standard' treatment portals for this radiation technique, 
only based on bony structures at the simulation films. They do not use routinely 
CT-based planning. 
Therefore, standardization of the target volume seems warranted. To design 
correct treatment portals for this group of patients, the American Gynecologic 
Oncology Group has recommended to use the bony landmarks of the pelvis 
[11], but this does not seem to be correct in all cases [13]. Intraoperative 
measurements seem to be the most accurate [10]. The precise location of the 
lymph nodes can be determined with a preoperative bipedal lymph angiogram 
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[5,19,25]. However, this procedure, being burdensome to the patient, may be 
unnecessary in a large number of cases. In this group of patients only a few will 
in fact need postoperative radiation because of positive lymph nodes [12,20]. 
Therefore, we have tried to define a three-dimensional reference target 
volume for these patients including the para-aortic region [26], using 47 
Iymphangiograms to locate the position of the para-aortic and iliac lymph 
nodes. In this reference target volume the para-aortic lymph nodes were 
included, although only one-third of the participants considered the para-aortic 
lymph node region as part of the CTV. For this group of radiation oncologist 
the reference PTV will be helpful in defining correct portal images, also for 
extended field radiation. Most of the radiation oncologists however will 
irradiate the pelvis only. Computer tomography data of IS patients after surgery 
for cervical carcinoma, compared with anatomical encyclopaedias, were used to 
assess the extent of the parametria at the pel vic wall. This reference PTV 
appeared to be up to I cm wider at the site of the pelvic rim and the left para-
aortic lymph nodal chain than the target volumes and treatment portals we 
commonly use. The reference target volume was covered by 41 % of the 
treatment plans of the radiation oncologists at the level of the parametria and by 
40% at the level of the para-aortic lymph nodes. Moreover, in the para-aortic 
region none of the treatment portals covered the PTV with a margin of more 
than 5 mm, particularly on the left side of the para-aortic lymph nodal chain, 
where the lymph nodes are located more laterally at the renal hilus, as seen on 
the lymphangiograms. 
A standardization of treatment volumes based on this reference PTV and 
CT-data allows for a more adequate design of treatment portals. Also, when 
using sophisticated 3-D conformal radiotherapy, this reference CT-based PTV 
can provide possibilities to reduce the volume of irradiated small bowel, while 
maintaining a high tumour control rate. 
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Appendix 1. 
Questionnaire postoperative irradiation of early stage cervical carcinoma. 
I. Would you advise to irradiate this patient postoperatively? 
2. If not. why? 
3. What techniques are used for patient positioning. do you use laser lines 
and/or fixation materials? 
4. Describe the target volume (CTV) and delineate the Planning Target 
Volume (PTV) the way used in your institute, on the enclosed simulation 
films and contours. 
5. What margin do you take between the target volume and the field 
borders? Draw the field borders on tbe simulation films. 
6. What energy would you use in a "normal" patient (diameter 24 cm)? 
7. Describe the radiation technique used in your institute. 
8. Do you use (computer)planning and if so, how many contours do you 
use? 
9. How do you prescribe the dose? 
10. Do you take positioning inaccuracy into account and in what way? 
11. What is the total dose, dose fractionation and number of fractions a 
week? 
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Abstract 
Purpose: Reduction of irradiated small bowel volume, using a conformal three-
dimensional treatment planning technique in postoperative radiotherapy of 
cervical cancer patients, 
Methods and Materials: Large gynecological treatment fields including the para-
aortic nodes were analyzed in 15 patients, A conventional treatment plan with 
anterior and posterior (AP-PA) parallel opposed fields and a 3D four fields 
conformal radiotherapy plan with a central blocking of small bowel were 
compared for each patient Dose volume histograms and dose parameters were 
established, Because of the tolerance constraints of the small bowel, the 
cumulative dose applied to the target was 48,6 Gy. 
Results: The mean Tumor Control Probability (TCP) values for both the 
conventional and the conformal technique were 0.60 and 0.61 respectively, with 
ranges of resp. 0.56-0.67 and 0.57-0.66. The mean volume receiving 95% or more 
of the prescribed dose (V95) of the small bowel was 47.6% (32.5-66.3%) in the 
AP-PA technique and 14.9% (7.0-22.5%) in the conformal technique [p < 0.001], 
indicating a significant reduction in irradiated volume of small bowel in the higher 
dose range. The mean Normal Tissue Complication Probability (NTCP) decreased 
from 0.11 to 0.03 with the conformal plan. In patients who received a pedicled 
omentoplasty during surgery, the mean V95 for small bowel could be reduced to 
8.5% (7.0-9.9%). 
The mean median dose to the kidneys was only slightly elevated in the conformal 
treatment Especially the mean dose to the right kidney in conventional versus 
conformal treatment was 3.3 versus 7.9 Gy. The mean near-minimum dose (D95) 
to the rectosigmoid decreased from 48.4 Gy to 30.1 Gy in the conformal plan 
compared to the conventional plan. 
Conclusion: The small bowel dose can be significantly reduced with 3D treatment 
planning, particularly if a pedicled omentoplasty is performed. This allows dose 
escalation to the tumor region without unacceptable toxicity for the small bowel. 
70 
3D-treatment planning in cervical carcinoma 
Introduction 
Patients with cervical carcinoma, FIGO stage Ib-IIa are often treated by surgery, 
consisting of radical hysterectomy and pelvic lymph node dissection. 
In case of histologically proven lymph node metastasis, postoperative 
radiation is frequently instituted. The target area usually consists of the small 
pelvis and, in some centers, the para-aortic lymph nodal region. 
Emami et al. [9] have reported the incidence of para-aortic nodal metastasis 
by stage ranging from 0-8% (stage I), 5-44% (stage II), and 10-45% for stage m. 
In fact, prophylactic para-aortic irradiation is an issue which is currently 
unresolved. However, Rotman et al. [26] did demonstrate a benefit in overall and 
distant metastasis free survival in patients with stage Ib (bulky), IIa and lIb. Also 
after follow up of 5 years [7,27] overall survival was significantly better for those 
treated with extended fields compared to those treated with pelvic radiation (resp. 
44% vs. 55%; p = 0.02). It is suggested by several authors that especially patients 
with histologically proven lymph node metastasis in the pelvic area might have 
benefit of electi ve para-aortic irradiation [2, 23]. In this specific group of 
postoperative patients we therefore chose treatment with extended fields. 
If patients are to receive postoperative radiation to both pelvis and the para-
aortic region, a large volume is treated, encompassing the primary tumor region, 
the proximal part of the vagina, the parametrial region, the pelvic lymph node 
regions (obturator and iliacal) and the para-aortic region to the level of lumbar I. 
For a total dose of 48-50 Gy, the most important dose limiting organ is the small 
bowel, especially after surgery when a significant part of the small bowel is 
located at the level of the pelvis and fixed by postoperative adhesions [10]. 
With a "standard" three or four-field box technique, the dose to the kidneys 
might exceed the tolerance dose. Therefor, most radiotherapy clinics treat this 
volume by AP-PA technique [9,14,20,23,24,27]. 
Several authors have emphasized that CT-treatment planning is needed for 
patients requiring four-field pelvic radiotherapy, because of a high incidence of 
inadequate margins at the primary tumor region [16], as well as the lymph node 
regions [3]. We developed a three-dimensional (3D) treatment planning technique 
based on CT -planning for the larger target area, including the para-aortic region. 
The dose volume histograms (DVHs) [6] of target and critical organs for the 3D 
treatment planning technique versus the APIPA technique were analyzed. 
Methods and materials 
From January 1995 until October 1996, 15 patients were referred to the 
University Hospital Rotterdam - Daniel den Hoed Cancer Center for postoperative 
radiotherapy after radical hysterectomy and lymphadenectomy. All patients had an 
7l 
Chapter 5 
adenocarcinoma or squamous cell carcinoma, stage Ib-IIa, of the cervix and 
histologically proven lymph node metastasis in the obturator and/or iliacal region, 
In two out of 15 patients a pedicled omentoplasty was performed to reduce the 
volume of small bowel in the pelvis, draping the omentum in the left paracolic 
gutter covering the vaginal vault In all patients the same target volume was 
irradiated, regardless of the number of positive nodes, To reduce toxicity a 3D 
conformal treatment planning technique was developed, 
All patients had a postoperative CT-scan in supine position, which extended 
from the top of thoracic vertebra 8 to the introitus of the vagina in I cm slice 
increments, Small bowel contrast was given 20-30 minutes before the scanning 
procedure in 8 patients, To visualize the lymph node regions, intraveneus contrast 
was applied, 
Protocol summary 
The Clinical Target Volume (CTV) consisted of the proximal two third of the 
vagina, the primary tumor region, the parametrial region to the fascia of the 
obturator internus muscle and the levator ani muscle, next to the pelvic walls, The 
CTV also contained the obturator node area on both sides. In the iliac region the 
CTV consisted of the external iliacal area from the posterior part of the inguinal 
ligament and the whole internal nodal area as well as the region of the common 
iliacal node chain. The para-aortic part of the CTV contained the nodal area from 
the level of the common iliacal nodes to the pedicles of lumbar I. 
A computer program [29] was used to obtain a 3D margin of 10 mm around 
the CTV to achieve the Planning Target Volume (PTV). This margin, albeit 
somewhat arbitrary, was chosen to cover for inaccuracy in positioning of the 
patient and mobility of the target area. Creutzberg et al. [5] showed that overall 
systematic differences between simulation and treatment images for the position 
of the gynecological patient in the field were 4.0 mm (one standard deviation 
[SD]) in the lateral direction and 4.2 mm in the craniocaudal direction, using laser 
lines and marking of the caudal field border. Little is known about the mobility 
during radiotherapy of retroperitoneal structures. The retroperitoneal part of the 
CTV is assumed to be relatively tight to vessel and nerve structures. We estimated 
a margin of IO mm as the 95% confidence interval (2 SD) for positioning and the 
mobility of the CTV. 
The position of the vagina, especially the top, might be influenced by the 
filling of rectum and bladder. 
The normal tissues which were considered were the kidneys, the small bowel 
and the rectosigmoid. The specific end points used in calculating their normal 
tissue complication probabilities were resp. clinical nephritis, 
obstruction/perforation and obstruction/proctitis [4,8LThe small bowel, including 
the mesenterium, was outlined on the CT-scan at the most exterior line of the 
bowel wall and/or mesenterium. The rectosigmoid was outlined as the exterior 
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wall, including any possible feces, starting at the first slice of the CT-scan which 
contained both sigmoid and rectum and all the way down to the anal canal. 
To standardize the procedure as much as possible, the CTV was defined and 
contoured on each slice for all patients. All patients were planned for the 
conventional non CT-based AP-PA portals (which were digitized) and for the 
conformal technique to compare the dose volume histograms. 
Dose prescription and treatment technique 
The dose prescription for the whole PTV was 48.6 Oy in fractions of 1.8 Oy per 
day, 5 fractions per week. The dose in the conformal technique was specified 
according to the ICRU 50 protocol [15]. The ICRU point was chosen as the 
intersection point of the beam axes at the first slice of the CT -scan which was 
located above the femoral heads, because this slice always contained the primary 
tumor region, i.e. the cervical and parametrial area, and because the dose is more 
homogeneous in this region. The dose in the conventional technique was specified 
in the midline, at the beam axes. 
All treatment plans were calculated with 25 MV photon beams and Multileaf 
Collimation (MLC) with a projected leaf width at the isocenter of 1.25 em'. 
The conventional technique consisted of two parallel opposed AP-PA fields 
with blocking of small bowel, kidneys and part of the hips. The field borders were 
determined by bony structures. The dose was specified in the midline of the 
patient. 
The conformal technique basically consisted of four fields, namely two 
parallel opposed AP-PA and two parallel opposed lateral fields. In this technique 
a central block for the small bowel at the level of the small pelvis is used, i.e. 
between the legs of the iliacal lymph nodal regions. To create the possibility of a 
central block with the MLC, we used one large AP-field which contained the 
entire PTV, except the left iliacal nodes, together with a small AP-field consisting 
of the left iliacal part of the PTV only. In the large P A-field, the right iliacal nodes 
(together with the small bowel) were blocked, followed by a small PA-field for 
the right iliacal region. Technique shown in Figs. 5-1 and 5-2. The exact position 
of the small bowel block is determined on the basis of dose distributions per CT 
slice. {In case of massive involvement of posterior (common iliac) nodes, the 
central shielding should be reduced or even omitted because of the risk of 
presacral involvement). 
The minimal margin between PTV and field edge in lateral direction turned 
out to be 0.7 cm. In cranial and caudal direction these margins had to be 1.0 cm 
and 1.6 cm, respectively, primarily due to the narrow PTV at these sides. The field 
weight of the lateral and PA-fields was 1.0; the weight of the AP-field(s) was 
0.75. The source-isocenter distance was 100 cm in all fields. 
I, Scanditronics MM50 Racetrack Microtron. 
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Three-dimensional dose distributions were calculated for each plan. The 
dose distributions in transverse plots at all levels of the PTV were evaluated. In 
case of underdosage at the caudal part of the PTV of more than 5%, the leaves 
were withdrawn up to 0.5 cm to dissolve the underdosage. 
Cumulative dose volume histograms (DVHs) were obtained for the PTV and 
critical organs as small bowel, kidneys and rectosigmoid for each patient and 
mean DVHs for all 15 patients were plotted. Also the mean of the difference 
between DVH for conformal and conventional plans were plotted, together with 
the standard deviation (SD). 
Probabilities for tumor control (TCP) [13, 23] and normal tissue complication 
(NTCP) [18, 22] were calculated. In the algorithm for TCP calculation, a uniform 
dose of 48.6 Gy was equated to a TCP of 0.6 for microscopic disease. For the 
NTCP calculation, the parameters from Emami et al. [8] were used. 
Statistics summarizing the dose distribution in the PTV and critical normal 
tissues included: V95: the volume receiving 95% or more of the prescribed dose; 
D5: the dose equalled or exceeded in 5% of the volume (near-maximum dose); 
D50: the median dose (equalled or exceeded in 50% of the volume), and finally, 
the D95: the dose equalled or exceeded in 95% of the volume (near-minimum 
dose). 
Plan evaluation was conducted by two clinicians and involved: 
1. Reviewing the isodose curves on the monitor of the treatment planning 
computer to obtain an overall impression of the dose distribution achieved. 
2. Reviewing the DVHs, TCPs and NTCPs and statistics for each normal tissue at 
risk. 
3. Analyzing "hot or cold spots" in transversal dose distributions and if necessary 
apply corrections in leaf position. 
Results 
Planning target volume and tumor control probability 
The mean PTV of all 15 patients had a total volume of 989 cc (range 718-
1206 cc). 
The mean values of TCP, V95, D5, D50 and D95 are shown in Table 5-1. 
There appears to be no significant difference in tumor coverage between the 
treatment techniques. In the conformal technique the mean V95 was slightly better 
for the PTV (99.1 vs 96.7%). In Fig. 5-3 the mean cumulative dose volume 
histograms for both techniques, averaged over all patients, are plotted with the 
mean difference in volume between the techniques with standard deviations. In 
Fig.5-3a the mean DVH for the PTV is shown. The dose distribution in the 
conformal technique is somewhat more homogeneous. 
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(b) 
Figure 5~ 1 a and 5-1 b 
Conformal therapy: CTV and PTVwith leafposition in AP~direction. Blocking of the small bowel and left 
iliacalnodes (a); treatme11l of the left Waca! nodes only (b). 
Figure 5-2 
Conformal therapy: CTV and PTV with leaf position in right lateral direction. 
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Normal tissue coverage and complication probabilities. 
Table 5-1 summarizes the mean dose statistics and NTCP values for the normal 
tissues studied. 
Small bowel 
The mean V95 was 47.6% (range 32.5-66.3) in the AP-PA technique and 14.9% 
(range 7.0-22.5) in the four-field technique, indicating that a significantly smaller 
part of the organ receives a high dose in the conformal technique [p <0.00 I with 
student T-test]. 
The D5 to the small bowel for the conventional plans exceeded the D5 for the 
conformal plans with an average of 1.8 Gy. 
Figure 5-3b shows the mean cumulative DVHs of both treatment plans with 
the mean difference in volume for allIS patients. Obviously, the advantages of 
the conformal technique versus the AP-PA portals are particularly found in the 
higher dose region, as in the lower dose region the small bowel in the conformal 
plan receives a higher dose because of the addition of the lateral portals. The 
significance of a low dose to a relatively larger volume of bowel is not well 
known. 
The mean NTCP value of the small bowel for the conventional plan was 0.11 
(range 0.07-0.18) and 0.03 (range 0.Ql-0.05) for the conformal technique, 
reducing the chance of severe complication significantly [p < 0.001 with student 
T-test]. 
In Fig. 5-4 the dose volume histogram for small bowel is shown for 1 of the 
2 patients with the pedicled omentoplasty. Particularly in this group of patients, in 
which the small bowel is partly elevated out of the small pelvis, shielding of the 
central part of the bowel in the AP- and PA-fields is useful. Omentoplasty, 
together with the conformal technique with central blocking of the small bowel, 
reduced the V95 to 7.0 and 9.9% in these 2 patients. 
Kidneys 
As is shown in Table 5-1 the mean D50 for the right and left kidney is slightly 
higher in the conformal technique. The NTCPs in both treatment plans for both 
kidneys are 0.0. In Fig. 5-3 the mean dose volume histograms with the mean 
difference in volume are plotted for the left (c) and the right (d) kidney. 
Rectosigmoid 
The mean near-minimum dose (D95) to the rectosigmoid was 48.4 Gy (range 
41.6-50.6) for the conventional plan and 30.1 Gy (range 22.1-39.3) [p < 0.001 
with student T-test] for the conformal technique, indicating an advantage in the 
higher dose range. In Fig. 5-3e the mean dose volume histogram with the mean 
difference in volume for the rectum is shown. 
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Table 5~1. Comparison between conventional and conformal technique for 15 patients. Mean value 
with range for planning parameters for target and critical tissues. 
Conventional technique 
(N)TCP(%) V9S(%) DS(Gy) DSO(Gy) D9S(Gy) 
PTV 0.60 96.7 51.0 49.S 47.2 
(0.56-0.67) (96.2- 100) (49.4-52.9) (4S.4-51.1) (44.6-49.0) 
Small bowel 0.11 47.6 50.5 34.9 1.6 
(0.07 -O.IS) (32.5-66.3) (49.1-51.6) (5.0-49.0) (0.7-2.7) 
Rectum 0.01 9S.1 50.9 50.3 48.4 
(0.0-0.01) (S6.3-100) (37.9-55.S) (49.1-52.7) (41.6-50.6) 
Right kidney 0.0 0.5 17.8 3.3 1.3 
(0.0-0.07) (0.0-6.3) (1.9-46.5) (1.1-15.3) (0.4-2.5) 
Left kidney 0.0 2.3 2S.1 3.1 U 
(0.0-0.0) (0.0-lS.7) (3.3-49.4) (1.1-6.3) (0.4-2.4) 
Conformal technique 
(N)TCP(%) V9S(%) DS(Gy) DSO(Gy) D9S(Gy) 
PTV 0.61 99.1 50.7 49.4 47.6 
(0.57-0.66) (9S.7-100) (49.7-51.9) (49.1-50.7) (46.6-4S.6) 
Small bowel 0.03 14.9 48.7 27.5 4.6 
(0.01-0.05) 0.0-22.5) (47.4-49.5) (23.1-30.3) ( 1.3-8.2) 
Rectum 0.0 69.4 50.9 4S.2 30.1 
(0.0-0.0) (50.0-92.5) (49.1-55.6) (46.2-49.5) (22.1-39.3) 
Right kidney 0.0 0.Q3 25.6 7.9 1.5 
(0.0-0.0) (0.0-0.5) (4.1-30.5) (1.1-25.3) (0.4-2.6) 
Left kidney 0.0 0.7 2S.4 5.8 1.5 
(0.0-0.0) (0.0-2.5) (2.6-43.0) (1.0-12.6) (0.3-2.4) 
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Discussion 
In patients with cervical cancer, stage Ib-IIa with histologically proven lymph 
node metastasis in the obturator and/or iliacal region after surgery, postoperative 
radiotherapy might be of benefit for locoregional control [I, 11, 14, 17, 28]. 
Until recently, many radiation oncology departments were using parallel 
opposed fields in irradiation of the pelvis and the para-aortic nodes because of the 
position of the kidneys. By using a 3D four-field technique we were able to 
conform the dose to the prescribed target without surpassing the tolerance dose of 
critical normal tissues such as the kidneys. 
We started a randomized toxicity study in which the conventional non CT-
based APIP A-technique is compared with the conformal radiotherapy technique, 
and evaluated the techniques of the first 15 patients treated to a total dose of 48.6 
Gy. 
The mean calculated TCP values for both techniques were almost equal. The 
mean V95 was slightly better in favor of the conformal technique. 
Some parts of the normal organs at risk, including the small bowel and 
kidneys could be partly avoided in all beam directions. The separate block at the 
small bowel at the level of the small pelvis proved to be of additional value, 
reducing the mean V95 to 7.0-9.9%. An exeption for this central shielding should 
be made in case of massive involvement of posterior (common iliac) nodes. There 
could be a risk of involvement of presacral nodes which might be blocked by the 
central shielding. 
The mean NTCP for small bowel could be significantly reduced from 0.11 
to 0.03. V95 was reduced from 47.6 to 14.9%, indicating a significant reduction 
in irradiated volume in the higher dose range, somewhat at the cost of a higher 
volume of irradiated small bowel in the lower dose range. 
As was demonstrated by Logmans et al. [21], the patients with pedicled 
omentoplasty had a volume reduction of the small intestine in the pelvis. In these 
patients, the central shielding of small bowel between the iliacal regions in the 
AP- and PA-fields of the conformal treatment was most beneficial. 
In the conformal treatment the mean near-maximum dose to the small bowel 
was 48.7 Gy. Since at some levels of the para-aortic region the small bowel 
closely surrounded the target volume, it was inevitable that some parts of the 
small intestine received a dose equal or close to the target dose. In the literature, a 
variable increase in complications is observed in patients receiving over 50 Gy 
[19, 24], although in one study [26] doses ranging from 56-61 Gy were not 
significantly more hazardous than in case of pelvis irradiation only. 
To improve local control rates in this group of patients, dose escalation studies 
might be performed in future. In addition to using the presented 3D conformal 
treatment technique, a substantial part of the small bowel will be shielded by 
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positioning the patient in a prone position in a belly board device [12] for the 
booster dose in the pelvic region. 
However in pelvic radiotherapy an extensive analysis was done by Tait et al. 
to evaluate toxicity with conventional and conformal treatment [30]. No 
significant differences in acute toxicity could be detected. More data on late 
effects have to be available before dose escalation in cervical cancer can be 
performed, especially when the para-aortic region is included in the elective part 
of the treatment. In addition to potential dose escalation, we feel that the most 
essential part of the present CT-based technique is to define, standardize and 
delineate the CTV and plan the treatment fields in three dimensions as tight as 
possible, in contrast to the field definition with bony landmarks. The DVHs for 
small bowel indicate a significant reduction in the treated volume for the high 
dose region. Whether this contributes to a reduction of acute and late toxicity, has 
to be assessed from the present randomized study. 
It must be emphasized that plans delivering doses appropriate for elective 
treatment may impact normal tissues in ways that are highly specific for the 
particular patient being studied. Careful analysis of dose distributions throughout 
the treatment volume is required before treatment is undertaken. In this study, no 
specific account was made for daily movement of normal tissues in and out of the 
fields, which might increase or decrease the dose to those organs. 
Conclusion 
Three-dimensional treatment planning allows careful analysis of the dose to the 
small bowel and kidneys which are expected to be limiting factors in radiotherapy 
at this site. With the described conformal technique the dose to the small bowel 
could be significantly reduced without exceeding the dose to other normal tissues. 
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Abstract. 
Purpose: To reduce the volume of small bowel within pelvic treatment fields 
for gynecological cancer using a belly board device and to determine the 
accuracy of the prone treatment position. 
Materials and methods: Fifteen consecutive patients with a gynecologic 
malignancy who were treated with postoperative pelvic radiotherapy were 
selected for this study. The volnme of small bowel within the treatment fields 
was calculated for both the supine and prone treatment positions. The patients 
were treated in the prone position in a so-called belly board device. During 
treatment sessions electronic portal images were obtained. An off line setup 
verification and correction protocol was used and the setup accuracy of the 
positioning in the belly board was determined. 
Results: The average volume of small bowel within the treatment fields was 
229 cm3 and 66 cm3 in the supine and prone treatment respectively. which 
means an average volume reduction in the prone position of 64% (95% CI 56-
72%) • as compared to the supine position. 
For the position of the patient in the field, the systematic error defined by the 
standard deviation (SD) of the mean difference per patient between simulation 
and treatment images was 1.7 mm in the lateral direction, 2.1 mm in the 
craniocaudal direction and 1.7 mm in the ventrodorsal direction. On average, 
only 0.4 set-up correction per patient was required to achieve this accuracy. The 
random day-to-day variations were 1.9 mm (lSD), 2.6 mm and 2.3 mm 
respectively. Standard deviations of the systematic differences between patient 
positioning relative to the bellyboard were 6.2 mm in lateral direction and 9.1 
mm in craniocaudal direction. 
Conclusions: Treatment of gynecological cancer patients in the prone position 
using a bellyboard reduces the volume of irradiated small bowel. An off line 
verification and correction protocol ensures accurate patient positioning. Daily 
setup variations using the bellyboard were small (1 SD < 3 mm). Therefore for 
pelvic radiotherapy in patients with a gynecological malignancy, the use of a 
belly board is recommended. 
86 
Belly board device in pelvic radiotherapy 
Introduction 
Pelvic radiation therapy is often indicated in the treatment of patients with 
gynecological cancer. However pelvic radiotherapy to a dose of 45- 50 Gy 
causes severe late small bowel toxicity in 3 - 9 % of patients [3,15,18]. In 
order to decrease the volume of irradiated small bowel, various techniques have 
been used, e.g. surgical displacement of the small bowel out of the pelvis using 
mobilized omentum which is repositioned in the pelvis, or the placing of a 
synthetic prosthesis under the small bowel [16,17,21]. Some investigators have 
treated patients in the prone position with or without a bellyboard device to 
displace small bowel loops out of the pelvic fields. The use of an open tabletop 
[12], a bellyboard [20] or a small bowel displacement device [II] have been 
described. 
Using radiation techniques with patients in the prone position, the accuracy 
of daily patient positioning can be an uncertain factor. There are no data 
available concerning the positioning accuracy in the prone position for 
gynecologic malignancies, in contrast to prostate cancer or rectal cancer 
[4,19,22,23]. This study was carried out to investigate the reduction of 
irradiated small bowel volume by using a bellyboard device and to study the 
setup accuracy in the prone position. 
Patients and Methods 
Fifteen patients with a gynecologic malignancy (10 endometrial cancer patients, 
2 patients with sarcoma of the uterus and 3 patients with cervical cancer), who 
received postoperative pelvic radiotherapy, were included in this study. Patient 
age ranged from 49-79 years (mean 65 years). All patients were treated using a 
four-field box technique with shielding of parts of the small bowel, part of the 
rectum and the hip joints. A total dose of 46-50.4 Gy was given in 23-27 daily 
fractions of 1.8-2.0 Gy, using 23-25 MV photon energy in an overall treatment 
time of 4.5 to 5.5 weeks. The upper border of the treatment fields for cervical 
cancer was located between L3-L4, for sarcoma of the uterus between L4-L5 
and for endometrial cancer between L5-S 1. 
All patients were simulated and treated in the prone position using a so-
called bellyboard. This bellyboard is a device made of high impact polystyrene 
(HIPS)' with a thickness of 4 mm. The board contains 2 apertures; a large 
aperture in the center of the board for the belly region and caudally a smaller 
aperture for the pubic bone (Figure 6-1). For comfort, the lower part of the 
bellyboard has been adapted to support the upper legs. The bellyboard is used in 
2 Polymarin thermoforming BV. 
87 
Chapter 6 
combination with a prone pillow for head and arms and a small roll is placed 
under the ankles. In order to push the small bowel in cranial direction. the pubic 
bone must be positioned in the specially made 'pubic aperture'. This pubic 
aperture was marked with barium contrast to verify the position of the patient's 
pubic bone during simulation. 
During the simulation procedure, the small bowel was visualized using 
bariumcontrast, administered orally 20 minutes before the simulation started. 
Simulation radiographs in the anterior-posterior (AP) and right lateral directions 
were obtained in both the supine position and in the prone position using a 
bellyboard in order to compare the small bowel volume in the respective 
radiation fields (Figure 6-2). If the volume of small bowel within the treatment 
fields in the prone position was reduced, the simulation procedure was 
completed in this position and the patient was treated using the bellyboard. The 
isocenter position (posterior and lateral) was visualized using laser equipment 
and marked on the patient's skin by small tattoos and long axial ink lines. To 
enable a reproducible position of the patient in the belly board, the longitudinal 
isocenter position was marked on the device (Figure 6-3). 
For 12 of the 15 patients, the volume of small bowel within the treatment 
fields, in both the supine and the prone position, could be evaluated. In the AP 
and lateral radiographs, the areas where barium contrast was present within the 
fields in the supine and the prone position, were determined. In the other 3 
patients the small bowel was not sufficiently visualyzed on both radiographs. 
Following Letschert et al. [15], these areas were divided into a grid of I x I cm 
squares. The products of the segment lengths in the two projections were 
summated, in order to generate a measure of the small bowel volume within the 
treatment fields (Figure 6-2C) [7,15]. The volumes calculated for the supine and 
the prone position were compared and the reduction of irradiated volume of 
small bowel in the prone position was calculated. 
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Figure 6-1 
High impact polystyrene belly board for pelvic radiation treatment in prone position, used in 
combination with prone pillow for head and arms. The large aperture in the centre of the board is for 
the belly region and the small caudal aperture for the pubic bone (the pubic aperture is marked 10 
verify the position oj the patients pubic bone during simulation). 
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Figure 6-2 
Simulation radiographs in the anterior~posterior (AJ and lateral (B) direction in the supine position of 
a patient with an endometrial carcinoma after abdominal surgery. Radiographs in the anterior-
posterior (e) and lateral (D) direction in the prone position in the belly board of the same patient. 
The small bowel is visualized with Barium contrast. Vaginal tube for localization of the top of the 
vagina inserted. Pubic aperture is marked to verify the position of the patient's pubic bone during 
simulation. One of the four markers in the belly board for analysis of positioning in the board is 
visible underneath contrast area. Radiograph C also shows the division of contrast areas into a grid 
of 1 xl em squares (same applies for lateral direction). 
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Figure 6-3 
Patient positioned in the helly board with isocenter position (posteriorly and laterally) marked on tile 
skin, using long laser lines and small tattoo points. The longitudinal isocenter position is marked on 
the belly board. 
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As the patient setup in prone position was expected to be less reproducible 
than in the supine position, the accuracy of daily patient positioning in the prone 
position in the belly board was determined using an EPID3 During setup the 
position of the beliyboard on the treatment table, and the position of the patient 
in relation to the bellyboard, were determined using lateral and sagittal lasers, 
The lateral tattoo points were the most important parameters for setup, 
During the treatment sessions portal images were obtained, An off-line 
verification and correction protocol was used [2, I 0,22] to verify the position of 
the individual patient during four subsequent fractions in order to ascertain the 
systematic setup deviation for that patient At each of these fractions, the 
position of the patient was calculated off-line and the three-dimensional 
displacement vector of the isocenter with respect to digitized simulator films 
was tested against a preset action leveL The initial action level for correction 
was 12 mm, based on previous studies in gynaecological patients [4,13,22], The 
action level shrunk at each subsequent fraction; after N measurements, the 
action level was the initial action level divided by the square root of N, The 
setup error which was tested against this level is the length of the mean 
displacement vector over N measurements, After a setup correction, again 4 
measurements had to be performed, If, after 4 subsequent measurements, the 
action level was not exceeded, the setup accuracy was next verified (and 
corrected if necessary) by means of weekly measurements, During these weekly 
measurements the average displacement over the last 4 measurements was 
tested against the lowest action leveL This protocol was proven to be a useful 
tool to reduce systematic setup errors in previous studies [2], 
Bony structures (pelvic rim and sacrum) were used to determine the setup 
errors in the posterior and lateral fields. Differences between the simulation and 
treatment positions were calculated in all directions and the mean errors and the 
standard errors of the mean were determined. The mean (M) is the average of 
the mean error per patient, over all patients. The random error (0) is the 
standard deviation of the day-to-day variations, averaged over all patients (i.e. 
the interfraction variation), whereas the systematic error (L) is the standard 
deviation of the mean error per patient (i.e. the interpatient variation). From 
these data, the random and systematic errors if no correction protocol was used, 
were derived by calculation. 
The position of the bellyboard with respect to the treatment field was 
analysed in the PA fields by comparing the position of 4 lead markers in fixed 
positions within the bellyboard to their position on the simulator films. Next, 
the position of the markers was compared with the position of bony structures 
of the patient (sacrum and pelvic rim). Thus, the movement of the patient with 
3 Philips SRI 100 for 10 patients. Siemens Beam View Plus for 5 patients. 
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respect to the bellyboard was determined. The markers in the bellyboard were 
only visible in the PA direction (as they fell outside the lateral treatment fields). 
Therefore this analysis was limited to translations in lateral and craniocaudal 
directions. 
Data analysis 
For each of the 12 patients which could be evaluated for the volume of small 
bowel within the treatment field, the reduction in prone position was determined 
and the mean reduction was calculated. 
For all 15 patients the mean setup deviation and standard deviation (SD) of 
the variation around that mean were determined in the medio-lateral and cranio-
caudal direction. Then the mean-of-means M, the variation of means l: 
(systematic error) and the mean of variations ('j (random error) were calculated. 
Statistical correlation of data was performed with the linear correlation test, 
using the Stata ™ program. In all cases a two sided significance level of 5 % 
was used and the linear correlation coefficient r was determined. 
Results 
Volumes 
For 11 out of 12 patients, the volume of irradiated small bowel in the prone 
position using the bellyboard was reduced as compared to the supine position. 
(See Table 6-1). 
The mean small bowel volume within the fields in the supine position was 
229 em' (range 4-529 em'), while in the prone position using the bellyboard 
this mean volume was 66 em] (range 0-174 cm\ The mean reduction of small 
bowel volume in the treatment fields was 163 em' (64% with 95% CI 56- 72%) 
with a range of 0-496 em] (0-100%). 
Positioning 
Data on the accuracy of patient positioning were available for all 15 patients. A 
total of 142 treatment sessions were imaged, an average of 9.5 per patient. In 
each treatment session 3 fields (PA, left lateral, right lateral) were imaged and 
analysed. Measured translations are shown in Figure 6-4. The plots show the 
mean translations in all three directions and standard deviations of the 
distribution of measurements for each patient, using the correction protocol. For 
all patients, the overall set-up deviations for translations in lateral, cranial-
caudal, and ventral-dorsal direction are presented in Table 6-2. Using the 
correction protocol, the average number of corrections per patient was 0.4. The 
calculated systematic errors which would have occurred without using the 
correction protocol were about twice as high as the value of the systematic 
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errors with correction protocol (see also Table 6-2). These results are similar to 
the ones found in a multicenter study for prostate patients (systematic errors in 
x, y and z-direction in our institution without correction protocol were resp. 2.9, 
2.1 and 3.3 mm) [2]. 
Table 6-1. 
Comparison of small bowel volume within the treatment fields in the supine and the prone 
position. 
Small bowel volume Supine (cm3) Prone (cm3) Reduction (ern') Reduction (%) 
Patient number 
I 217 35 182 84 
2 141 64 77 55 
3 35 0 35 100 
4 394 25 369 94 
5 529 33 496 94 
6 500 148 352 70 
7 169 56 113 67 
8 301 174 127 42 
9 328 165 163 50 
10 4 4 0 0 
II 102 93 9 9 
12 28 0 28 100 
Mean (95 % CI) 229 66 163 (138-188) 64 (56- 72) 
For analysis of the position of the patient in the belly board, we have used 
the same definitions as for the patient set-up data, i.e. L is the SD of the 
systematic shifts relative to the simulation films and cr is the SD of the random 
variations. The translations were calculated in lateral and craniocaudal direction 
only, for reasons mentioned in the methods section. The results are shown in 
Table 6-3. Relatively large systematic errors in lateral (Lx) and craniocaudal 
(LY) directions were found for the patient shift relative to the bellyboard 
markers. Especially LY appeared to be more than 9 mm. There appeared to be 
no correlation between the patient variation in the bellyboard in x-direction 
(based on the marker analysis) and variation of the position of the patient within 
the treatment fields (r=0.06, p=0.45). However a larger translation between 
simulation and treatment in the y-direction of the patient in the belly board 
resulted in a significantly larger value of LY in the patient set up (r=0.27, 
p=O.OOI). Also a correlation was found between the patient diameter (range 17 
to 22 ern with a mean of 20 cm) and cry (the random patient variation in the 
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beUyboard in y-direction); with increasing patient diameter, the patient 
positioning in the craniocaudal direction was less accurate (r=0.55, p=0.05). 
Table 6-2. 
Accuracy of patient positioning within the treatment fields (patient setup accuracy in mm). 
Mx My Mz ax ay az Lx 
In case no correction 0.7 -1.8 -0.9 1.9 2.6 2.3 2.5 
protocol was used 
With correction protocol 0.3 -0.8 -0.4 1.9 2.6 2.3 1.7 
M = mean of means (mean error per patient. averaged over all patients) 
x = patient positioning elTor compared to the treatment field in lateral direction 
y = positioning error in cranial-caudal direction 
.::: = positioning error in ventral-dorsal direction 
Ly Lz 
3.7 3.6 
2.1 1.7 
a = random error (standard deviation of the day-to-day variations. averaged over all patients) 
£= systematic error (standard deviation afthe mean error per patient) 
Table 6-3. 
Positioning of the patient in the bellyboard; position of markers in comparison to bony 
structures of the patient (fiducial marker analysis in mm). 
Mx My ax ay Lx Ly 
marker 0.7 -1.3 5.5 4.8 6.2 9.1 
M = mean of meanS 
x = patient positioning error compared to bellyboard markers in lateral direction 
y = positioning error in cranial-caudal direction 
(j = random error 
I = s·ystematic error 
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Discussion 
Small bowel toxicity is the main cause of morbidity and the dose-limiting factor 
during pelvic radiotherapy [3,7,9,14,20]. Prevention of radiation enteritis using 
special techniques and/or tools reducing the risk of acute and late 
complications, is therefore needed. 
Surgical and non-surgical procedures to displace small bowel out of the 
irradiation fields have been investigated [16,17,21]. Treatment in the prone 
position using a bellyboard has been shown to be an effective technique to 
minimize the volume of irradiated small bowel in pelvic radiotherapy [3,5-
7,9,14,18,20]. However when patients are treated in the prone position, the 
substantial setup error-rate, especially in elderly or obese patients, is of reported 
concern [19,20]. 
In this study the volumes of small bowel within the treatment fields in the 
supine position and the prone position were compared, yielding a mean 
reduction of 163 cm3 (64% with 95% CI 56- 72%) when using the prone 
position in the bellyboard. In the power law model, described by Letschert e.a. 
[15], data on small bowel complications are related to the equivalent total doses 
for several small bowel volumes. The complication rate for a small bowel 
volume V is calculated by a logistic function, using the ratio between V and a 
reference small bowel volume Vee" For the volume exponent 11, they found a 
value of 0.26 ± 0.05. If we use this power law model for our data to calculate 
the increase of total dose to maintain the same complication rate, a mean 
reduction of irradiated small bowel volume of 229 to 66 cm3 means an increase 
of the iso-effect dose of 38% «VIV"Jr026 ). However, the advantage strongly 
varies due to the great interpatient variation of small bowel volume within the 
treatment field. Other studies showed similar results [3,5,6,20]. 
Holst e.a. described a small bowel displacement device that is fixed to the 
treatment table [II]. A disadvantage of this method can be the difficult 
verification of patient positioning in relation to the device after the patient has 
been positioned. Moreover, lateral or longitudinal table motions will disturb the 
location of the device in relation to the treatment field center. Shanahan et al 
[20] used customized bellyboards made for each patient individually which is 
more expensi ve and time consuming. 
Using a standard bellyboard, only one or two devices in a linac room are 
needed. No extra time is needed to position the device on the table and patients 
can be positioned easily. In our experience, patients seem to tolerate the device 
easily, in spite of previous abdominal surgery, especially if the device was used 
in combination with a prone pillow. 
The average daily random set-up variations in our study were small ( I SD < 
3 mm ). The individual patient range in daily setup variation is I to 4 mm. 
These results are better than the setup variations for gynecologic pelvic fields 
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treating patients in the supine position [4,13], Thus, the prone position in a 
bellyboard in combination with a prone pillow was proved to be reproducible 
for pelvic radiotherapy in gynecological patients, Perhaps positioning using skin 
markings on the back in stead of the abdominal skin, contributes to the 
reproducibility. 
The patient positioning in the bellyboard showed much larger systematic 
errors (2:x=6.2, 2:y=9.1 mm) than the treatment field analysis (2:x= 1.7, 2:y=2.1 
mm). The largest systematic error was observed for the craniocaudal direction. 
We can only speculate that at the simulation procedure the patients were not yet 
used to the position in the pubic aperture, while during the treatment sessions 
this became more comfortable. Therefore, the systematic error for positioning in 
the bellyboard might partly be due to rotation of the pelvic rim. However from 
the EPID images we found that the positioning of the patients in relation to the 
treatment fields was accurate (Table 6-2). An alternative explanation could be 
that the patient positioning accuracy is more dependent on the adjustment of the 
laserbeams to the skin marks than on the patient positioning in the belly board. 
This hypothesis is supported by the observation that not only the systematic 
errors but also the random errors are larger in relation to the belly board than to 
the treatment fields. 
In this study a patient positioning off-line correction protocol was used with 
an initial action level for correction of 12 mm. Using this protocol the resultant 
systematic errors in x, y, and z-direction were very small (1.7 - 2.1 mm), which 
is comparable with the accuracy of positioning obtained in radiation treatment 
of prostate cancer patients [J ,2] and means a significant reduction in 
comparison with systematic errors in gynecological patients from previous 
studies without a correction protocol [4,8,10]. There was an average of only 0.4 
corrections per patient due to the relatively small random deviations. For future 
positioning studies for gynecologic patients in our institution, a correction 
protocol with an initial action level of 9 mm will be used. 
It is clear that the prone position with a standard bellyboard provides a 
significant reduction of irradiated small bowel volume in gynecologic patients 
(Table 6-1). Analysis of the variation of patient positioning using an off-line 
correction protocol showed decreased random and systematic errors in 
comparison with previous studies. The prone position in a bellyboard has 
therefore been introduced in our department as the standard positioning 
technique for pelvic radiotherapy in gynecological cancer patients. 
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Chapter 7 
Abstract 
Purpose: Positioning of patients with gynecologic tumors for radiotherapy has 
proven to be relatively inaccurate. To improve the accuracy and reduce the 
margins from clinical target volume (CTV) to planning target volume (PTV). 
on-line set-up corrections were investigated. 
Methods and Materials: Anterior-posterior portal images of 14 patients were 
acquired using the first six monitor units (MU) of each irradiation fraction. The 
set-up deviation was established by matching three user-defined landmarks in 
portal and simulator image. If the two-dimensional deviation exceeded 4 mm, 
the table position was corrected. A second portal image was acquired using 30 
MU of the remaining dose. This image was analyzed off-line using a semi-
automatic contour match to obtain the final set-up accuracy. To verify the 
landmark match accuracy, the contour match was retrospectively performed on 
the six MU images as well. 
Results: The standard deviation (SD) of the distribution of systematic set-up 
deviations after correction was < 1 mm in left-right and cranio-caudal direc-
tions. The average random deviation was < 2 mm in these directions (1 SD). 
Before correction, all standard deviations were 2 to 3 mm. The landmark match 
procedure was sufficiently accurate and added on average 3 minutes to the treat-
ment time. The application of on-line corrections justifies a CTV-to-PTV 
margin reduction to about 5 mm. 
Conclusions: On-line set-up corrections significantly improve the positioning 
accuracy. The procedure increases treatment time but might be used effectively in 
combination with off-line corrections. 
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Introduction 
Geometric uncertainties in radiotherapy 
Confonnal radiotherapy aims at limiting tOXiCity of critical organs while 
maximizing the tumor dose. This goal can be partly achieved by minimizing the 
treatment field size. The treatment field size is mainly detennined by the size of 
the tumor including subclinical disease and by the margins applied to compensate 
for geometric uncertainties that occur during radiotherapy. Following the 
nomenclature proposed by the International Commission on Radiation Units and 
Measurements (ICRU), the gross tumor volume plus subclinical disease is called 
clinical target volume (CTV), and the CTV plus safety margins is called the 
planning target volume (PTV) [I]. Minimization of these so-called CTV-to-PTV 
margins, i.e. restraining internal tumor movement and maximizing the patient set-
up accuracy, will therefore benefit confonnal radiotherapy. 
Set-up accuracy of patients with gynecologic tumors 
Patients with gynecologic tumors seem somehow more difficult to positlOn 
accurately on the treatment couch than patients with prostate cancer [2], which is 
treated in the same pelvic region. Rather large set-up deviations have been 
reported in the literature [3-5]. In recent years, several set-up techniques have 
been investigated in our institute as well [3,6]. However, they all yielded more or 
less the same distributions of random (day-to-day) set-up variations; the average 
standard deviations (0') were about 3-4 mm in each of the three main directions. 
Since the simulator film which is used as reference image can be considered as 
one sample from those distributions, it is plausible that the standard deviation of 
the distribution of systematic (everyday) set-up deviations for the whole patient 
group (L) initially had similar values [7]. 
Off-line set-up corrections 
The only significant improvement of the set-up accuracy was obtained by 
application of an off-line set-up verification and correction protocol [2,7,8]. The 
set-up deviations of subsequent fractions are averaged and compared with an 
action level that decreases with the square root of the number of measurements. If 
the average deviation exceeds the action level, a table correction will be applied to 
the following fractions and the protocol is restarted. The procedure stops if a 
specific number of measurements is perfonned without correction. Using such a 
protocol with about ten measurements per patient, the systematic variations for 
patients with gynecologic tumors were reduced by a factor two [6], as for patients 
with prostate cancer [2]. Random variations are not affected by the off-line 
protocol. 
105 
Chapter 7 
CTV-to-PTV margins 
In our institute, the CTV -to-PTV margin for patients with gynecologic tumors is 
mainly determined by the set-up deviations; the internal CTV movement is 
considered to be relatively small (although this is the subject of an on-going 
study). Using the off-line protocol, a margin of 1 cm can be applied. This is based 
on previous research which concluded that the margin should be equal to at least 
22:+0.7cr to guarantee an adequate tumor dose [9]. Inserting 2: = 2 mm and cr = 4 
mm in this formula, results in margins of only 7 mm. However, this value is 
rounded up to I cm because of other geometric inaccuracies such as delineation 
uncertainty and internal organ motion. 
On-line set-up corrections 
To increase the cure rate, we are currently considering to raise the tumor dose for 
some patients with gynecologic tumors to 60 Gy. In the literature, it has been 
reported that maximally 30% of the small bowel volume should receive a dose of 
over 55 Gy [10,11]. With the current CTV-to-PTV margins, it is not always 
possible to fulfil this criterion for tumor doses higher than 55 Gy. Reduction of 
margins might be justified if an on-line instead of an off-line set-up protocol is 
applied. With on-line corrections, the set-up deviation is determined and corrected 
before the (bulk of the) daily treatment dose is given. Other groups have reported 
superior set-up accuracies at the cost of increased treatment time [5,12-18]. In this 
paper, we will discuss whether on-line set-up corrections are beneficial and 
clinically feasible in our institute. 
Methods and materials 
Treatment planning and immobilization 
Fourteen patients with gynecologic tumors were included in the study. The 
patients were irradiated with a four-field box technique if the CTV could be 
restricted to the primary tumor region, the proximal two-third of the vagina, the 
parametria, and the obturator and iliac lymph nodes. If the CTV included para-
aortic lymph nodes, anterior-posterior/posterior-anterior (APIP A) fields were 
used. The CTV -to-PTV margin was I cm. The APIP A patients were treated with a 
source-to-skin distance of 100 cm, whereas the box technique was isocentric. The 
total dose varied from 46 to 48.6 Gy and the number of fractions from 23 to 27. 
All patients were treated in supine position at the same accelerator4 with 25 MV 
photons and a multileaf collimator. 
.. M.M50 Racetrack Microtron. Scanditronix Medical AR UppsaJa. Sweden 
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For patient positioning, long lateral, sagittal and transversal laser lines were 
marked on the patient. The intersection points of these lines were tattooed, 
together with the caudal field border. A knee roll was used to decrease the pelvic 
rotations and a homemade foot support further secured foot and leg position. The 
legs were slightly exorotated to ensure decreased muscle tension in the legs and 
the buttocks. The arms were positioned above the head by a commercially avail-
able arm support5 In case of discrepancy between the skin marks in longitudinal 
direction, the caudal field border tattoo was the decisive parameter for set-up 
[3,6]. For isocentric treatments, the isocenter-to-table distances were used for 
table height position. The focus-to-skin distance was measured before each 
fraction. 
On-line correction protocol 
To determine the deviations in patient set-up, the position of bony structures in 
AP portal images were compared with corresponding positions in a reference 
image. The portal images were acquired with a commercially available electronic 
portal imaging device (EPIDt The technical characteristics of this system were 
described in previous publications [19,20]. An on-line set-up correction procedure 
was developed using the high-level script language designed to operate the EPID 
system automatically. The procedure can be separated in four steps: 
I. Before treatment, the operator selects a maximum of three anatomical land-
marks in a digitized simulator radiograph (i.e. the reference image), which is 
displayed on a monitor. For all treatment fractions, these landmarks will 
reappear automatically in the reference image. Useful landmarks for AP pelvic 
images are the pubic symphysis and the intersections of horizontal and vertical 
tangents to the pelvic rim [5], as indicated in Fig. 7-la. 
2. The patient is positioned on the treatment couch and a portal image is obtained 
using the first 6 monitor units (MU) of the treatment dose, after which the 
irradiation is automatically interrupted. The image quality is improved by 
automatic adjustment of the display contrast. Landmarks similar to those in the 
reference image must be defined in the portal image. The image quality of a 6 
MU image is usually sufficient to discriminate most of the bony structures, as 
is shown in Fig. 7-lb; however, in some cases the pubic symphysis can be less 
pronounced. In case of extreme set-up deviations, the pelvic rim can partially 
disappear behind the field defining blocks. However, normally at least two 
landmarks can be indicated to enable image registration. 
5 Sinmed BY, Reeuwijk, The Netherlands 
6 SRI-l (}{), Electa Oncology, Crawley. Great Britain 
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a) simulator imaQe b) 6 MU MV imaqe 
c) on-line match results d) 30 MU MV imaqe 
Figure 7·1 
771e on-line set-up correction procedure. In (a) the digitized simulator image is shown in which three 
reference landmarks are defined (crosses, x). Next, (b) a 6 MU EPID image is obtained in which the same 
landmarks are seLected (numbered plusses, +). The landmarks are matched (c) and table translations are 
shown. A correction must be pe'formed if the 2D vector is larger than 4 111m. Finall.'" (d), 0.30 MU EPID 
image is acquired of the final set-up position in which the reference landmarks are shown to verify the 
correction. 
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3. The patient position is determined by calculation of the difference between the 
center-of-mass of the landmarks in the portal and the reference image. If the 
two-dimensional (2D) set-up deviation is larger than 4 mm (i.e. about equal to 
one standard deviation of the expected variations), the patient couch is trans-
lated as indicated (Fig. 7-1 c). Rotations can generally not be determined and 
corrected in a fast and reliable manner; in case of rotations, the selected 
landmarks are matched as well as possible by translations only. Since two 
landmarks are placed near the top of the pelvic rim and one at the pubic 
symphysis, the position of the top largely determines the outcome of the 
match. Once the match has been performed, the set-up position is immediately 
obtained; a separate field edge match is superfluous because the stiff 
mechanical structure of the EPID box ensures a reproducible and known 
isocenter position in the images. 
4. With the remaining dose a 30 MU image is made, which is used for off-line 
determination of the final set-up position (see contour match section). To be 
able to immediately verify an applied correction, the 30 MU image is displayed 
on the monitor with the reference landmarks, which should be in the correct 
position (Fig. 7-ld). 
To be effective, the on-line procedure must run at each fraction of the 
treatment. To estimate the extra workload involved with the on-line protocol, the 
time required for landmark match and table correction was monitored for some 
patients treated toward the end of the study. At that time, the start-up problems 
had been solved and the technicians were familiar with the procedure. Since 
lateral images were available for a limited number of patients and since the largest 
variations were expected to occur in the cranio-caudal direction [3,6], only AP 
fields were used for on-line corrections. 
Contour match 
To determine the accuracy of the on-line landmark match, all 6 MU images were 
retrospectively analyzed by contour matching as well. Contour matching was 
impossible with the EPID software, but is judged to be more reliable than 
landmark matching because a larger fraction of the anatomical structure to be 
matched is actually used in the calculation. To determine the accuracy of the final 
treatment set-up, the 30 MU images were analyzed with the contour match as 
well. 
The contour match procedure was developed using specialized visualization 
software'. It semi-automatically registers two images, in this case an EPID image 
with the corresponding digitized simulator radiograph (Fig. 7-2). 
7 A VS, Advanced Visual Systems, Waltham, MA 
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contour match 30 MU imaae 
Figure 7~2 
Illustration of the contour match procedure. In the upper left image the reference image is shown with a 
manuall.v drawn contour (gray in this black·and·white image). In the upper right image, a 30 MU EPID 
image is shown in which a similar structure is contoured (bLack). The two small images il1 the middle 
depict the binary images used for the cross correlation match. The match resuLt is visualized in the lower 
right image; where the black and gray contour overlap, the contours become light gray. Resulting 
translation values and patient data are shown in the bottom left. 
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For both images, the image quality can be improved using display 
equalization, which locally optimizes the display contrast [21], In both images, the 
features to be matched must be outlined manually, The contours are subsequently 
converted to black-and-white binary images, the contours being white on a black 
background, The cross-correlation function of the two binary images is calculated 
using Fast Fourier Transforms, The position of the maximum of this function 
gives the translation between the two images, Jones and Boyer [22] used this 
method to determine the shift between two original megavoltage images directly, 
Since in our approach binary images are used instead of mega voltage images, the 
position of the maximum is more sharply defined and less dependent on gray 
scale variations, However, in case of rotations the delineated structures in the two 
images may differ in shape, which might cause a (partial) mismatch of the 
delineated structures if the contours are too thin, Therefore, the line thickness of 
the contours in the binary images can be increased and is usually about ten pixels 
(5 - 8 mm), The value of the maximum (between 0 and 1) can be considered a 
correlation coefficient reflecting the adequacy of the match, Values larger than 0,7 
normally indicate sufficiently correct matches (accuracy < 1 mm), To obtain an 
estimate of the in-plane rotations, the rotation with the maximum correlation is 
determined for a range of rotations around the image center, using the translated 
images as starting point The calculation of translations took about 20 seconds on 
a UNIX workstationS, the rotations added another 10 seconds, 
The structures in the MV images used for matching the AP images are also 
indicated in Fig, 7-2, The superior part of the pelvic rim is judged to be the best 
indicator of the target volume position, because it is visible in all images and near 
the center of the field, The inferior pelvis and symphysis are not included because 
they are particularly sensitive to out-of-plane rotations around the lateral axis, The 
contours thus defined have a center-of-mass similar to that of the landmarks used 
to determine the on-line corrections, The two match methods will therefore treat 
(out-of-plane) rotations similarly, 
Statistical analysis 
For each patient i the mean set-up deviation (111.;) and the standard deviation (SD) 
of the variation around that mean (sd;! were determined in the left-right and 
cranio-caudal directions, Next, the mean-of-means M (= MEAN mil, the 
variation-of-means 2: (= SD 111.;), the mean-of-variations (j (= MEAN sdi), and the 
variation-of-variations v (= SD sdi) were calculated for both patient groups, Mis 
normally close to zero; there should be no systematic difference between average 
set-up on the simulator and on the accelerator for a large group of patients, In that 
case, 2: gives an indication of the size of systematic deviations for the individual 
patients; therefore, 2: is called the systematic variation, Since (j represents an 
s HP715!75, Hewlett Packard, Palo Alto, CA 
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estimate of the average random variation, it is called the random varzatlOn, 
Finally, v indicates the degree of variation in random deviations per patient, i,e, it 
is a measure of the homogeneity of the mobility in the patient group, 
Statistically significant differences of these four variables between the 
corrected and uncorrected group were investigated using the student's T-test for 
the mean values and an SD test as described by Hoel [23] for the standard 
deviations. Furthermore, a possible correlation between (uncorrected) set-up 
variation and patient diameter (in AP and lateral direction) was investigated. For 
patients treated with APIP A fields, patient diameters were only available in the 
AP direction. 
Results 
On-line set-up correction procedure 
The total number of on-line set-up measurements for the 14 patients in the study 
was 254 (varying from 9 to 23 per patient). In 32 measurements (13%), only two 
instead of three landmarks could be identified, mostly due to insufficient visibility 
of the pubic symphysis. In 57% of cases the initial 2D set-up deviation exceeded 
the 4 mm action level and a correction was applied. Set-up deviations as 
calculated by the contour match for all patients and all fractions before and after 
corrections are shown in Fig. 7-3. The 202 measurements for which the contour 
match results before and after correction were both available are indicated. The 
mean values per patient are also indicated. Both systematic and random variations 
are clearly reduced after the corrections. This is confirmed by the results of the 
statistical analysis as shown in Table 7-1. Systematic variations (2:) and random 
variations (0') which were 2 to 3 mm before corrections significantly decreased (p 
< 0.01) to < I mm and < 2 mm (I SD) after corrections, respectively. 
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Figure 7-3 
Scatter plots of the set-up deviations for each fraction before and after the on-line corrections. The gray 
square dots are the patient means, the black dots are the individual measurements for eachjraction. The 
reduction of systematic as well as random set-up positiol1 variations after on-line corrections is obvious. 
Rotations and correlations 
The contour match yielded rather small values for in-plane rotations. The overall 
standard deviations were smaller than I degree with extremes less than 4 degrees 
in all cases. Although there was a relation between the patient diameter in AP 
direction and the standard deviations of lateral set-up inaccuracies, the 
correlations were not significant (p = 0.09, r = 0.47). Other correlations between 
diameters and set-up deviations were even less significant. 
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Table 7-1. 
The set-up accuracies as determined by the contour matches for 14 patients with 
gynecological tumors. Accuracies in the left-right (6.x) and crania-caudal C6.y) direction are 
indicated in mm, before and after on-line corrections. For the explanation of M, L, G, and v, 
see the methods section. 
M IT V 
.6.x (before corrections) 0.9 2.0 2.3 0.7 
Ay -0.2 2.8 3.0 1.3 
.6.x (after corrections) -0.2 0.7 1.6 0.5 
!"y -0.5 0.6 1.8 0.3 
Comparison of match methods 
For 2!O measurements, both the landmark match and the contour match results of 
the set-up before correction were available. The same technicians (SQ and MS) 
performed all contour matches, whereas the on-line landmark matches were done 
by any technician present at the accelerator (under supervision of SQ and MS). 
Scatter plots of contour match versus landmark match results are shown in Fig. 7-
4. The average difference between the two match procedures was 0.3 +/- 1.1 mm 
(1 SD) in the lateral direction, and 0.4 +/- 1.8 mm (1 SD) in the cranio-caudal 
direction. Both average values are significantly different from zero (p < 0.0 1), 
which implies that there is a small systematic difference between the two 
methods; this might be caused by the center-of-mass of the three landmarks, 
which can be slightly different from that of the contours. The variation in the 
lateral direction is appropriate, considering that the reproducibility of each method 
separately is about 0.5 - I mm (1 SD). The larger variation in the cranio-caudal 
direction is probably due to the larger pixel size in that direction (0.8 mm cranio-
caudal VS. 0.5 mm lateral at isocenter), and due to the out-of-plane rotations 
around the left-right axis. Consequently, the match accuracy of the on-line match 
significantly contributes to the final set-up variation in this direction. 
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Figure 7.4 
Scatter plots of the set-up deviations as measured with the contour match versus the landmark match for 
left-right (a) and cranio-calldal directions (b). The 4 mm lines are shown to indicate the fractions which 
have definitely been corrected (the 2D action level was 4 mm). The variation around the ideal one-la-one 
line immediately shows that there is some difference between the fwo match methods. 
Treatment time 
The extra treatment time for the on-line procedure per treatment fraction varied 
from 1-2 minutes if no table translation was required, to 3-5 minutes if a table 
correction was necessary. Considering a standard treatment time per patient of 10 
minutes, this corresponds to an increase in time of 10-20% without and 30-50% 
with correction. The variation is due to differences in image quality and user 
experience. The extra treatment time was required for determination of the set-up 
position (1 min), restart of the accelerator (30 s), and the table correction pro-
cedure (2.5 min). 
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Discussion 
Comparison with previous studies 
The measured set-up variation before correction is largest in cranio-caudal direc-
tion, which is consistent with previous in-house studies [3,6]. However, 
particularly the systematic variation in the cranio-caudal direction was already 
significantly lower (p = 0.02) than for the patients in the previously reported 
mattress study [6], even though set-up technique and accelerator were identical. 
The average patient obesity was also similar. The extra attention the patients 
received due to the protocol might already result in better set-up accuracy before 
correction, especially because only one accelerator and a limited number of 
technicians were involved in the study. Furthermore, the match technique, e.g. the 
anatomical structures used for matching, has altered slightly in the course of time. 
In this study, extra attention has been given to consequent delineation of the same 
match structures, which is essential in case of out-of-plane rotations. 
Although a significant correlation between patient diameter in AP direction 
and lateral set-up accuracy has been reported before [5], the low correlation in this 
study make this diameter a rather weak predictor for set-up accuracy. It is 
therefore impossible to individualize set-up protocols and PTV margins according 
to patient diameter. 
Benefit of on-line set-up correction procedure 
As expected, patient set-up was significantly improved using the on-line 
verification and correction procedure. The 4 mm action level resulted in random 
variations after correction of 1.5 - 2 mm. Since the systematic variations are 
reduced to < I mm and the margin to cover for geometric variation of the CTV 
with respect to the beam portals can be approximated by 22:+0.7a [9], a CTV-to-
PTV margin for external set-up accuracies of 3 mm will suffice. An even better 
set-up accuracy can be obtained by decreasing the action level. In principle, the 
maximum accuracy is limited by the accuracy of matching software and treattnent 
equipment. This will off course yield more corrections and an increase in average 
treatment time. 
Fig. 7-5 shows the dose volume histograms of a patient with a gynecologic 
tumor planned to a dose of over 60 Gy with two different CTV -to-PTV margins: 
the current clinical margin of 1 cm and a 5 mm margin for on-line corrected 
patients (the 3 mm is rounded up to include other uncertainties than set-up 
deviations). With a margin of 5 mm instead of 1 cm, the volume receiving a small 
bowel dose larger than 55 Gy is reduced from the critical 30% to an acceptable 
15%. 
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PTV 
" \ 
Dose volume histograms of a patient with a gynecologic lLmlOr, which show a reduction in small bowel 
dosage when smaller CTV-to-PTV margins are applied. Until 48.6 Gy, the CTV consists of the primal)' 
tumor region plus the elective para-aortic lymph nodes, the boost is given on the primary tumor region 
only. Use of 5 !11m CTV-to-PTV JI1nrgins (gray lines), which is justified {f on-line corrections are 
pelfor111ed instead of the currently applied J cm (black lines), reduces the small bowel volume receiving 
55 c.-v or more. to less than 20%. 
Extra treatment time 
In case of a correction, the extra treatment time was 3 to 5 minutes. During the 
study, new table settings had to be entered at the treatment console and the patient 
couch had to be moved accordingly by a technician in the treatment room. 
However, further automation of the accelerator after the study has enabled fully 
automatic table corrections within 1 minute. This reduces the overall extra time in 
case of correction to about 2.5 minutes. Since about half the number of fields had 
to be corrected, the average extra time per fraction per analyzed field is now about 
2 minutes. Because it takes two images to determine the 3D patient set-up, a total 
of 4 minutes per fraction are maximally needed, which is comparable to most 
other studies [12,13,15,17,18] and to the routinely used off-line protocol in our 
institute. Furthermore, elaborate set-up equipment such as mattresses and foot and 
arm supports also require extra time. One might argue that in most cases the 
patient set-up technique can be fast and basic as long as on-line corrections can be 
applied. 
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Recent and future developments 
Since we expect that on-line correction of patient set-up (and possibly tumor 
position) will become an important tool for conformal radiotherapy in the future, 
we have developed a new portal imaging device especially equipped for on-line 
applications 9 The device obtains better quality images with I MU than the "old" 
EPID system with 6 MU, Furthermore, fully automated and fast contour matching 
will be implemented in the software, which is expected to reduce the total time for 
on-line corrections to about I minute per field. Finally, the image resolution of the 
new system is significantly improved as well; radioopaque markers can now be 
visualized, which might be used to measure and possibly correct the internal CTV 
position in patients with gynecologic tumors on-line. 
Combination of off-line and on-line set-up correction protocol 
To minimize the current treatment time at the accelerator, a combination of an off-
line and on-line protocol is applied for routine patient set-up. Table 7-1 and 
previous studies show that the inter -patient variation (v) was rather large for 
patients with gynecologic tumors. Therefore, initially all patients are treated using 
the off-line procedure. Only those patients with large random variations, and 
hence with repeated corrections in the off-line protocol, are entered in the on-line 
correction protocol. Furthermore, systematic variations can be determined during 
the course of treatment with the on-line protocol as well; instead of identical 
corrections each day after 6 MU, table corrections can be applied beforehand 
(similar to the off-line protocol), which further decreases the treatment time. 
Conclusion 
The on-line patient set-up correction protocol resulted in a significant 
improvement of set -up accuracy. This allows for the use of smaller PTV s, which 
might in turn allow dose escalation while maintaining acceptable complication 
probabilities for the small bowel. Since we believe that in the future on-line set-up 
corrections will be used on a more routine basis, the speed and accuracy of the 
procedure are being improved. Until this has been achieved, a combination of off-
and on-line set-up correction protocols will yield optimal set-up accuracy with a 
minimal workload. 
Acknowledgements 
This research was supported by a grant from the Dutch Cancer Society (NKB 
project 92-86). 
<) Cab Ion Medical, Leusden, The Netherlands 
118 
On-line setup corrections during radiotherapy 
References 
[I] International Commission on Radiation Units and Measurements, ICRU 
Report 50: Prescribing, recording, and reporting photon beam therapy. 
Bethesda, MD: 1993. 
[2] Bel A, Vos PH, Rodrigus PTR, et aI. High precision prostate cancer 
irradiation by clinical application of an off-line patient setup verification 
procedure, using portal imaging. Int J Radiat Oncol BioI Phys 
1996;35:321-332. 
[3] Creutzberg CL, Althof VG, de Hoog M, et al. A quality control study of the 
accuracy of patient positioning in irradiation of pelvic fields. Int J Radiat 
Oncol BioI Phys 1996;34:697-708. 
[4] Mitine C, van Eyken E, Nickers Ph, et al. Pelvic irradiation: influence of 
technique of set-up on the accuracy of field alignment. Radiother Oncol 
1994;32(Suppl l):S 146. 
[5] Van den Heuvel F, De Neve W, Verellen D, et al. Clinical implementation of 
an objective computer-aided protocol for intervention in intra-treatment 
correction using electronic portal imaging. Radiother Oncol 
1995;35:232-239. 
[6] Quint S, Seven M, de Hoog M, et al. Positioning gynecological patients for 
conformal radiotherapy using vacuum mattresses, Abstract 4th Int. 
Workshop on Electronic Portal Imaging, Amsterdam, The Netherlands, 
1996. 
[7] Bijhold J, Lebesque N, Hart AA, et al. Maximizing setup accuracy using 
portal images as applied to a conformal boost technique for prostatic cancer. 
Radiother On col 1992;24:261-271. 
[8] Bel A, van Herk M, Bartelink H, et al. A verification procedure to improve 
patient set-up accuracy using portal Images. Radiother Oncol 
1993;29:253-260. 
[9] Stroom JC, de Boer JCJ, Huizenga H, et al. Inclusion of geometrical 
uncertainties in radiotherapy treatment planning by means of coverage 
probability. Int J Radiat Oncol BioI Phys. 1999;43:905-919. 
[10] Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to thera-
peutic irradiation. Int J Radiat Oncol BioI Phys 1991 ;21: I 09-122. 
[II] Munzenrider JE, Brown AP, Chu JC, et al. Numerical scoring of treatment 
plans. Int J Radiat Oncol BioI Phys 1991 ;21 : 147-163. 
[12] De Neve W, Van den Heuvel F, Coghe M, et al. Interactive use of on-line 
portal imaging in pelvic radiation. lnt J Radiat Oncol BioI Phys 
1993;25:517-524. 
[13] De Neve W, Van den Heuvel F, De Beukeleer M, et al. Routine clinical 
on-line portal imaging followed by immediate field adjustment using a 
tele-controlled patient couch. Radiother Oncol 1992;24:45-54. 
119 
Chapter 7 
[14] Balter JM, Sandler HM, Lam K, et al. Measurement of prostate movement 
over the course of routine radiotherapy using implanted markers, Int J Radiat 
Oncol Bioi Phys 1995;31:1 \3-118, 
[15] Luchka K, Shalev S, Pelvic irradiation of the obese patient: a treatment 
strategy involving megavoltage simulation and intratreatment setup correc-
tions, Med Phys 1996;23:1897-1902, 
[16] Ezz A, Munro P, Porter AT, et al. Daily monitoring and correction of 
radiation field placement using a video-based portal imaging system: a pilot 
study. Int J Radiat Oncol Bioi Phys 1992;22:159-165. 
[17] Gildersleve J, Dearnaley DP, Evans PM, et al. A randomised trial of patient 
repositioning during radiotherapy using a megavoltage imaging system. 
Radiother OncoI1994;31:161-168. 
[18] Van de Steene J, Van den Heuvel F, Bel A, et al. Electronic portal imaging 
with on-line correction of setup error in thoracic irradiation: clinical evalu-
ation. Int J Radiat Oncol Bioi Phys 1998;40:967-976. 
[19] Althof VG, de Boer Je, Huizenga H, et al. Physical characteristics of a 
commercial electronic portal imaging device. Med Phys 1996;23:1845-1855. 
[20] Visser AG, Huizenga H, Althof VG, et al. Performance of a prototype 
fluoroscopic radiotherapy imaging system. Int J Radiat Oncol BioI Phys 
1990;18:43-50. 
[21] Moseley J, Munro P. Display equalization: a new display method for portal 
images. Med Phys 1993;20:99-102. 
[22] Jones SM, Boyer AL. Investigation of an FFT -based correlation technique 
for verification of radiation treatment setup. Med Phys 1991; 18: 1116-1125. 
[23] Hoel PG. In: Introduction to Mathematical Statistics. 5th ed. New York: 
John Wiley & Sons; 1984. p. 279-300. 
120 
CHAPTERS 
GENERAL DISCUSSION, FUTURE DIRECTIONS AND 
CONCLUSIONS 
Chapter 8 
The mean age of patients with cancer submitted for radiation treatment is 
increasing. In the daily practice of radiation oncology departments, older cancer 
patients often are excluded from clinical trials and sometimes are undertreated, 
due to the assumption that normal tissue tolerance decreases with increasing 
age. However recent clinical studies have shown that normal tissue toxicity in 
the elderly is probably not increased compared to cancer patients of younger 
age groups [2,11,16,19,20,23,29,30]. This controversy needs to be resolved. 
Experimental data on the relation between aging and normal tissue toxicity can 
provide a stronger foundation for further clinical decision making on this 
important issue. In particular data on late effects are missing. Moreover, toxicity 
being a relevant issue in the young- as well as in the older patients, even to the 
extent that it can be dose (cure) limiting, modern treatment techniques, such as 
3-D conformal radiotherapy, have created the opportunity to reduce the risk of 
normal tissue toxicity substantially. Both issues, that is experimental 
observations on the ageing effects of irradiated rectal mucosa (animal data) and 
the sparing capacity of 3-DCRT are reported in this thesis. 
8.1. The influence of aging on the toxicity of irradiated mucosa of the rectum 
Previous experiments on the development of radiation induced changes in the 
rectum of young- and old Wi star rats after single doses of irradiation, using 
clinical and radiological endpoints, showed that there were no significant 
differences in the incidence of rectal stenosis and the development of a 
megacolon [17]. 
The histopathological evaluation after two single radiation doses at early 
time points as 1, 2, 4 and 10 weeks after treatment (Chapter 2) showed small, 
non significant age related differences. Ulceration seemed to be an important 
feature as it showed a clear dose, age and time dependency. Severe vascular 
changes as occlusion of blood vessels occurred significantly more often in both 
of the sections of the irradiated area and already at 4 weeks after treatment in 
the old group, while in the young rats this was observed less frequently and 
only at 10 weeks. The regenerative capacity of the mucosa might be influenced 
by vascular changes after radiation. 
In accordance with other investigators [9], we found a significant increase 
in the number of proliferative cells in the rectum adjacent to the treated area in 
the older group at 1 week after 22 Gy, in contrast to the young animals where 
only a small increase was observed. This suggests a different age-related 
reaction pattern. 
To elucidate whether the observed (small) differences lead to long term 
effects, we also studied late time points as 24 and 52 weeks after irradiation 
(Chapter 3). In both age groups the incidence of late mucosal ulceration 
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appeared to be lower than in the early time points, which confirms the 
occurrence of regeneration, The increase in cell proliferation in the first week in 
the adjacent areas of the irradiated field, might be an important factor in the 
healing process of the initial ulceration in the older rats, 
The total radiation injury score (RIS) expressed the total damage within the 
irradiation field of the rectum, In the young animals after a dose of 22 Oy, the RIS 
gradually increased with a clear dose dependency, After 39 Oy and in the older 
group after both doses, the RIS appeared to be high at 2-4 weeks and remained 
high at the longer follow up periods. There were no significant differences 
between the age groups, but these data do support the hypothesis that late rectal 
damage is a consequential effect of acute damage. 
The clinical outcome with longer follow up in both age groups was similar. 
Obviously, these data cannot be translated to the clinical practice in a simple 
fashion. First of all we have limited our research to one normal tissue only; 
moreover, the mucosa of the rectum in Wi star rats could behave dissimilar to 
the rectal mucosa of humans. Secondly, the geriatric population is a highly 
diverse population in terms of function, co-morbidity, social support, cognitive 
function and emotional status. The elderly patient might suffer from more than 
one clinical problem, whether somatic, psychological and/or socio-economical. 
This multifactorial complexity can impose limitations in daily life functioning 
and determines the final quality of life score. However, from these animal data 
it seems reassuring that, at least in Wistar rats, there is no extra-morbidity to be 
expected due to ageing per se from radiating normal tissues such as the rectal 
mucosa. 
8.2. Standardization of CTV 
Besides collecting more experimental and clinical data on acute- and late side 
effects, more sparing types of cancer treatments have to be developed. In 
radiation oncology, the introduction of 3D conformal radiotherapy, which 
"tightly" conforms the radiation to the target and thereby spares the surrounding 
normal tissues, has provided challenging possibilities in this respect. However, 
a precise defmition and delineation of the target volume(s) is mandatory. 
In the study as outlined in Chapter 4, 17 radiation oncologists were asked to 
define the CTV and PTV and delineate the treatment portals on simulation films 
for postoperative radiotherapy in a patient with early stage cervical carcinoma 
with iliac node involvement. A reference PTV was defined by using data of 
normal Iymphangiograms and CT -data of the same group of patients. There 
appeared to be no agreement in the description of a uniform CTV by the 
participating radiation oncologists. The CTV could in fact be divided into three 
different CTV's with the most important controversy being the "yes or no" 
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inclusion of the para-aortic nodes in the CTV. Besides these different CTV-
definitions, there were also major variations in the shape and size of the treatment 
portals used within these three groups, probably due to uncertainties in the precise 
location of the primary tumor and the Iymphnode chains. A significant number of 
the participating centers appeared to have 'standard' treatment portals, based on 
bony structures visualized on the simulation films, while the current literature on 
the subject has shown that this could lead to a considerable risk for a geographical 
miss [13,25]. Our reference CT- and Iymphangiogram based PTV was covered by 
only 40% of the treatment plans at the level of the parametria as well as at the 
level of the para-aortic nodes. None of the treatment portals covered the para-
aortic region with a margin of more than 5 mm (needed for set up inaccuracy). 
From these observations we highly recommend (more) standardization in 
the definition of the CTV in cervical carcinoma, especially with regard to the 
elective parts. Based on these findings, the Dutch Group of Gynecological 
Radiation Oncology (LPRGT) is working on consensus guidelines for definition 
of target volumes in cervical cancer. Furthermore we think that the use of a 
CT-based planning is essential to prevent geographical misses and maximize 
sparing of normal tissues in this patient group. 
8.3. Three dimensional conformal treatment planning techniques 
The importance of CT -based treatment planning is also stressed in the study on 
cervical carcinoma, described in Chapter 5. In this study the conventional 
technique with AP-PA parallel opposed beams is compared to a 3D-planned 
technique for postoperative radiotherapy in 15 patients with early stage cervical 
carcinoma with histologically proven lymph node metastasis. The mean 
calculated values for the Tumor Control Probability (TCP) were almost similar. 
The mean Normal Tissue Complication Probabilities (NTCP) for the small 
bowel and the rectosigmoid could both be significantly reduced by the 
conformal technique. The volume of the small intestine which received :2: 95 % 
of the prescribed dose (V95) was significantly reduced from almost 48 % to 15 
%, which means a considerable reduction in the high dose range. The 
subsequent higher volume of irradiated small bowel volume in the lower dose 
ranges, due to the application of the lateral fields, could potentially lead to more 
low grade acute toxicity. This seems to be a frequently occurring effect of using 
multiple beam directions in conformal therapy. Its clinical relevance is not yet 
clear. Jackson e.a. [12] found in a study with conformal radiotherapy to doses 
of 70.2- 75.6 Gy in prostate cancer an independent association between rectal 
bleeding and large percentages of volume of the rectum exposed to intermediate 
doses (= 46 Gy). They conclude that this could indicate that a large surrounding 
region of intermediate dose may interfere with the ability to repair the effects of 
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a central high dose region. Further studies on this aspect are necessary, but 
might lead to more constraints in the treatment planning process in the near 
future. In fact, this might make the use of intensity modulated radiation therapy, 
with typical constraints on particular normal tissues, mandatory. 
With the reduction of dose to the small intestine, a booster dose to the pelvic 
region in microscopically involved areas, and therefore dose escalation, might be 
possible in the future, using conformal- and intensity modulated radiotherapy. In 
addition to using 3D treatment planning techniques, a substantial part of the small 
bowel can be shielded by positioning the patient in a prone position in a belly 
board device (Chapter 6). 
8.4. Volume-effect in reduction of toxicity 
The belly board device is extensively discussed in Chapter 6. In this study the 
reduction of irradiated small bowel volume using a belly board device in pelvic 
radiotherapy of gynecological cancer patients was measured. From this 
experience the patients seem to tolerate the device easily, in spite of previous 
surgery, especially if the device was used in combination with the prone pillow 
(Fig. 6.1). There appeared to be a mean reduction of small bowel volume within 
the treatment fields in the prone position compared to the supine position of 163 
cm] (64 % with 95% CI 56-72 %). It is clear that this advantage strongly varies 
due to the interpatient variation of small bowel volume within the treatment 
field. Hopewell and Trott [10] stated that volume effects are more related to 
organ anatomy and organ physiology than to cell survival data. Wachter e.a. 
[28] performed a prospective study on the rectum of patients who were treated 
with conformal radiotherapy for prostate cancer. A rectosigmoidoscopy was 
done 20-41 months after treatment. The topographical distribution of 
rectoscopic changes could be matched to the dose distribution along the rectal 
wall. Secondly, the extent and severity of local damage appeared correlated 
with clinical grades of proctitis. In 3D conformal therapy with high doses of 
radiation, studies that determine how to decrease the amount (volume) of 
normal tissues (e.g. bowel), albeit by technical means (belly board) or 3D 
treatment planning techniques, are indispensable. 
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8.5. Improvement of positioning 
The accuracy of patient positioning in the belly board was also studied using 
Electronic Portal Imaging Devices (EPID's) at the linear accelerator (Chapter 
6), The average daily random setup variations in our study using an off-line 
setup verification and correction protocol were small (l SD < 3 mm), with an 
individual range of 1- 4 mm, These results appeared to be better than setup 
variations for gynecologic pelvic fields treating patients in supine position in 
our institute [4], A possible explanation might be an increase of reproducibility 
by skin markings on the back instead of the abdominal skin, Therefore we 
introduced the prone position in a belly board as the standard positioning 
technique for pelvic radiotherapy in patients with gynecological cancer. In the 
correction protocol we used an initial action level of 12 mm, The systematic 
errors in x-, y- and z-directions were small (1.7 -2,1 mm), which means a 
significant reduction in comparison to positioning of gynecological patients of 
previous studies without a correction protocol [4], 
In contrast to an off-line correction protocol, the set-up deviation can be 
determined and corrected before the bulk of the daily treatment dose is given by 
an on-line correction protocoL This could mean a reduction of the margin of the 
PTV around the CTV which covers for the set-up variation (and other 
geometric uncertainties as delineation uncertainty and internal organ motion), 
This might lead to a decrease in toxicity; a reduction in the margin for the PTV 
might provide the possibility of dose escalation to increase the cure rate, In 
Chapter 7, a study with on-line set-up corrections in gynecological patients is 
described, We used a 4 mm initial action level which resulted in random 
variations of 1,5 -2 mm, Because the systematic variations were reduced to < I 
mm, the CTV -to-PTV margin to cover for external set-up inaccuracy could be 
reduced from 7 mm to 3 mm, The accuracy that can be obtained by on-line 
verification is limited by the accuracy of the measurements and the corrections, 
which depend on the accuracy of the accelerator, the treatment couch and the 
EPID, However the most important obstacle for clinical use is the extra time 
that is required to measure and correct the set-up on-line. In view of the waiting 
period for many patients for radiation treatment at this moment, this seems 
unacceptable for routine clinical application. Therefore we perform on-line 
corrections only in patients with large random set-up variations with an off-line 
correction protocoL A specific threshold in these patients reduces the amount of 
on-line corrections, while a high accuracy is maintained. 
8.6. Future directions 
8.6.1. Clinical assessment of the elderly population 
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It is obvious that older patients need a geriatric assessment before they enter a 
clinical trial with aggressive therapy. The National Cancer Center Network in 
the USA (NCCN) has recently proposed a number of guidelines related to the 
management of the older cancer patient to identify frail individuals who are at 
excessive risk, to identify co-morbidity and lack of social support and to assess 
life expectancy of the older cancer patient [1]. The first priority for clinical 
trials in older individuals appears to create a common language to account for 
and report on the diversity. In randomized trials with elderly patients, survival 
as an endpoint of outcome may not always be appropriate. Alternative 
outcomes, such as progression- and disease-free survival, clinical benefits, 
preservation of function and quality of life may be more difficult to evaluate, 
but for this population more worthwhile. 
8.6.2. New developments in conformal radiation treatment 
Recent improvements of treatment planning and techniques have provided the 
possibility to reduce irradiated volumes of normal tissues. This might lead to a 
decrease in late toxicity. Frequent and continued assessment of toxicity will be 
needed to determine whether the costs and the benefits are balanced. Quality of 
life forms scored by the patients themselves provide us invaluable information. 
However, before we can draw conclusions about reduction of toxicity by 
conformal treatment techniques, consenSUS on the definition of the CTV is 
needed as well as uniformity in delineation of the CTV. National working 
groups with representation of all centers in the Netherlands are working on such 
definitions for a number of tumor sites at this moment. Besides consensus on 
the definition of the CTV, more accuracy in the determination of the CTV is 
also needed. There can be inter- and intraobserver variations in the delineation 
due to inaccurate diagnostic images on CT of the borders of the CTV and 
surrounding normal tissues. This variability in tumor delineation has been 
investigated e.g. in cancer of the prostate and lung. Differences between 
physicians or between the same physician at different times can exceed I cm. 
[3,7,22,27,32]. Translation from other image modalities like MRI and SPECT 
to CT images and generation of new software to contour the different organs 
automatically will be subjects for further investigation. 
In the near future Intensity Modulated Radiotherapy (IMRT) as a form of 
conformal treatment, with dose constraints to particular normal (critical) tissues, 
will be applied clinically in our department on a routine basis. By varying the 
intensity of the beamprofiles of multiple beams, for instance by using dynamic 
multileaf collimation [6], surrounding tissues might be spared in a more optimal 
way. More research has to be focused on internal movement of surrounding 
organs, as well as movement of the primary tumor and the areas which have to 
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be treated electively. Many studies have been performed in prostate cancer, 
using a number of computed tomography (CT) scans for each patient 
[5,8,14,15,24,26,31], but data on other tumor sites of the pelvis are rare. In 
order to see whether we could reduce the CTV -to-PTV margin, we recently 
initiated a study on internal movement of the cervix and the uterus in patients 
with cervical carcinoma, marking the cervix with 2 to 3 surgical clips after 
which planning CT scans are obtained. During the radiation therapy CT-
scanning evaluates the position of the cervix (clips), the movement of the uterus 
and the influence of the rectum- and bladder volume. Frequent portal imaging 
with EPID is also performed to investigate whether the cervical markers move 
during the treatment period of 5 weeks. It is felt that a reliable off-line or on-
line verification- and correction protocol with EPID is indispensable in future 
radiation treatment techniques. 
According to some groups [18,21], there might be a potential gain in the 
future from dose individualization strategies based on both normal tissue dose-
volume data and radiosensitivity (assuming that reliable (molecular radiation 
biological) assays will become available). These new ideas might be of 
importance for the elderly population and provide reasons for maintaining an 
optimistic view. 
8.7. Conclusions 
In this thesis, experimental studies on the relation between age and radiation 
tolerance of normal tissues were combined with clinical studies on reduction of 
toxicity, using 3D-conformal treatment techniques. 
Based on the early and late histopathological evaluations of rectal damage 
of young and old rats, the assumption that radiation tolerance of rectal tissue has 
diminished with old age cannot be justified. For the individual patient, however, 
more data on radiation response of normal tissues in the elderly are needed, 
particularly in a clinical environment. Recent progress in 3-D treatment 
planning-, immobilization-, and verification techniques have provided the 
clinicians tools to further reduce volumes and dose of the irradiated normal 
tissues. 
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Introduction 
In radiation therapy of pelvic malignancies, small bowel and rectum often are 
the dose limiting organs due to the hazards of severe acute- and late toxicity. 
Especially pelvic tumors as prostate- and rectal cancer and gynecological 
malignancies frequently occur in the elderly. The assumption that normal tissue 
tolerance decreases with increasing age is often the basis for undertreatment in 
the elderly patient. However recent clinical studies strongly support the idea that 
tissue toxicity in patients older than 74 years of age is not increased compared 
with younger patients. Only limited experimental data are available addressing 
the influence of age on radiation sensitivity. Especially data with regard to the 
relation between ageing and late effects of radiation to normal tissues are rare. 
Chapter 1 discusses the relationship between the proportional increase of the 
aging population and the incidence of cancer as well as the application of 
cancer treatments in the elderly, in particular the application of radiotherapy. 
The radiation toxicity of the small intestine and the rectum are described, both 
clinically and histopathologically. Besides experimental studies on the relation 
between ageing and normal tissue tolerance for radiotherapy, modern treatment 
techniques which provide the opportunity to modify the doses in the critical 
organs such as small intestine and rectum are important in order to prevent the 
risk on late (irreversible) toxicity. 
Chapter 2: After experiments with single doses of irradiation on the rectum of 
young and old Wistar rats (12 and 78 weeks old respectively) with clinical and 
radiological endpoints, histopathological studies with two radiation doses (the 
LD20 and LD80, resp. 22 and 39 Gy) were performed. In this chapter early 
follow up time points as 1, 2, 4 and 10 weeks after treatment are described. 
In Chapter 3 the late effects of the radiation on the rectum are reported with 
evaluation time points of 24 and 52 weeks after treatment. At the early time 
points, after 22 Gy, 60 % of the old animals showed ulceration and a 
discontinuous muscularis mucosae in the part of the rectum within the treatment 
field due to severe damage, while the young rats had a continuous muscularis 
without ulceration. However after 39 Gy, ulceration was observed already at 1 
week after irradiation in the young group and only at 4 weeks in the older 
animals. At the late time points, the incidence of mucosal ulceration appeared to 
be lower in both age groups (0 -50 % at 52 weeks), indicating the possibility of 
regeneration. In contrast to the early time points, there appeared to be no 
difference between the age groups. A significant increase in the number of 
proliferative cells in the rectum adjacent to the treatment field at 1 week after 22 
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Gy which we found in the older group only, suggests a different age related 
reaction pattern. This early proliferation was also reflected in a significant 
increase of the number of endocrine cells in the crypts adjacent to the treated 
area of the old rats at 52 weeks. We consider these enteroendocrine cells as a 
non-specific result of cell proliferation. 
Severe vascular changes as occlusion of blood vessels also occurred 
significantly more often and earlier in the older animals, but as most of the 
observed (small) differences at the early time points, these differences did not 
lead to significant differences with longer follow up and the clinical outcome in 
the long term was similar. Based on these experiments, the assumption that 
radiation tolerance decreases with older age cannot be justified. More 
experimental and clinical data on radiation tolerance of normal tissues in the 
elderly are badly needed and clinical trials including older people may provide 
important answers in geriatric oncology. 
Chapter 4: In radiation oncology, the development of 3D-treatment planning 
and new treatment techniques have provided the opportunity to conform the 
radiation fields as much as possible to the individual situation (tumor) of the 
patient. This may lead to better sparing of the critical organs and, on the other 
hand, to escalation of the dose in the tumor area in order to increase the cure 
rate. In 3D-treatment planning with CT-based delineation, a precise defmition 
and deliniation of the tumor as weB as the surrounding normal tissues is 
mandatory. In this chapter, a study on differences in definition of the Clinical 
Target Volume (CTV) and Planning Target Volume (PTV) in postoperative 
radiation of a patient with cervical carcinoma is described. Seventeen Dutch 
radiation oncologists participated and defined the volumes and delineated the 
treatment portals on simulation films. These volumes were compared by a 
reference PTV, using data of Iymphangiograms and pelvic CT-scans of a large 
number of female patients. There appeared to be no consensus around the 
country about the definition of the elective parts of the CTV. The treatment 
portals as drawn on the films, mostly based on bony structures, did not cover 
the parametria of the reference PTV in 41 % and the para-aortic node region (if 
defined in the CTV) in 40 % of the cases. More standardization in definition of 
the CTV in different tumor sites is needed, especially in the elective parts of the 
CTV. 
In Chapter 5, a comparison is made between a conventional and a 3D 
conformal treatment technique is described in postoperative radiotherapy of 15 
patients with early stage cervical carcinoma and histologicaBy proven lymph 
node metastasis. The mean Normal Tissue Complication Probabilities (NTCP) 
for the small bowel and the rectosigmoid could both be significantly reduced by 
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the confonnal therapy technique. Further studies on the clinical outcome in 
reduction of toxicity are needed. 
Chapter 6: In pelvic radiotherapy. a prone position of the patient in a so called 
belly board device might decrease the volume of small bowel within the 
irradiation fields. Displacement of the bowel to the region above the fields is 
performed by an aperture for the belly region in the device. A study on the 
reduction of volume of irradiated small bowel in pelvic radiotherapy of 
gynecologic cancer patients, using the device, is described. There appeared to 
be a mean reduction in the volume of small bowel within the treatment fields of 
64 % (95 % CI 56 -72 %) in prone position in the belly board compared to the 
supine position on the treatment couch. At the same time, the accuracy of the 
positioning in the belly board was studied using Electronic portal imaging 
Devices (EPID's) using an off-line setup verification and correction protocol. 
The average daily random setup variations appeared to be small (I SD < 3 mm), 
which means a significant improvement compared to setup variations in supine 
position in these patients in previous studies in our institute. The mean 
systematic errors in x-, y- and z- direction in prone position were also small 
(1.7- 2.1 mm), using an initial action level for correction of 12 mm. 
Chapter 7: If the setup of a patient is verified and corrected after a small 
fraction of the daily treatment, before the bulk of the irradiation is given, a so 
called on-line correction protocol is used. This might lead to a reduction of the 
CTV-to-PTV margin which covers for the setup variation (among other 
geometric uncertainties). A significant reduction of this margin could lead to a 
reduction in toxicity and eventually to increasement of the dose to the primary 
tumor region. In Chapter 7, a study with on-line setup verification and 
corrections in gynecologic cancer patients is described. The initial action level 
for correction was 4 mm and resulted in random variations of 1.5- 2 mm. The 
systematic variations were reduced to < I mm, which lead to a reduction of 
CTV-to-PTV margin of 4 mm (from 7 mm to 3 mm). However, on-line 
verification and correction is more time consuming on the treatment machine 
and, because of the frequent treatment interruptions, more bothersome for the 
patient. On-line correction of the setup should therefore be used in cases with 
large random errors only. 
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Introductie 
Bij radiotherapie van maligniteiten in het kleine bekken, zijn zowel dunne darm 
als endeldarm de belangrijkste dosisbeperkende organen door het risico op 
ernstige acute en late bestralingsschade. In het kleine bekken gelokaliseerde 
tumoren zoals prostaat-, endeldarmkanker, en gynaecologische maligniteiten 
komen vaak voor op oudere leeftijd. Oudere patienten worden regelmatig 
onderbehandeld daar men van de veronderstelling uitgaat dat de tolerantie voor 
radiotherapie van normaal weefsel, afneemt met het stijgen van de leeftijd. 
Recent klinisch onderzoek heeft echter laten zien dat schade aan normaal 
weefsel bij patienten welke ouder waren dan 74 jaar, niet is toegenomen in 
vergeJijking met jongere patienten. Er is slechts op zeer beperkte schaal 
experimenteel onderzoek verricht naar de in vI oed van leeftijd op 
radiosensitiviteit. Vooral data met betrekking tot de relatie tussen leeftijd en late 
effecten van bestraling op normaal weefsel zijn zeldzaam. 
In hoofdstuk 1 wordt de relatie tussen de toenemende vergnJzmg en de 
incidentie van kanker beschreven. Tevens worden de mogelijke 
behandelingsvormen van kanker bij de oudere mens besproken, met name 
behandeling met radiotherapie. Oe ontwikkeling van bestralingsschade aan de 
dunne darm en de endeldarm, zowel klinisch als histopathologisch, wordt 
beschreven. Behalve experimentele studies naar de relatie tussen veroudering en 
tolerantie van gezond weefsel, zijn ook moderne behandelingstechnieken van 
belang die de mogelijkheid bieden om de doses in de kritieke organen zoals 
dunne darm en endeldarm, te modificeren, ten einde het risico op late 
(irreversibele) schade te beperken. 
Hoofdstuk 2: Nadat eerst experimenten werden uitgevoerd met bestraling van 
de endeldarm van jonge en oude Wistar ratten (respectievelijk 12 en 78 weken 
oud) met enkelvoudige doses en klinische en radiologische eindpunten, werden 
histopathologische studies verricht met een tweetal doses (de L020 en L080, 
respectievelijk 22 en 39 Gy). In dit hoofdstuk worden de vroege tijdpunten 
zoals 1, 2, 4 en 10 weken na bestraling beschreven. 
In hoofdstuk 3 worden de late effecten van bestraling van de endeldarm van 
Wi star ratten beschreven met tijdpunten van 24 en 52 weken na bestraling. Na 
22 Gy werd op de vroege evaluatie tijdstippen bij 60% van de oudere dieren 
u1ceratie gevonden met een discontinuiteit van de muscularis mucosae in het 
deel van de endeldarm binnen het bestralingsveld, terwijl dit bij de jongere 
dieren niet of nauwelijks het geval was. Echter na een dosis van 39 Gy, werd 
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u1ceratie bij de jonge groep al gezien na I week en pas na 4 weken bij de 
oudere ratten. 
Bij de late tijdstippen bleek de incidentie van u1ceratie van de mucosa lager in 
beide leeftijdsgroepen in vergelijking met de vroege evaluatie momenten (0-
50% na 52 weken), hetgeen een indicatie is voor het vermogen tot regeneratie 
van de mucosa. In tegenstelling tot de vroege tijdstippen was er geen sprake van 
een verschil in incidentie van u1ceratie tussen de beide leeftijdsgroepen. AIleen 
bij de oudere groep bleek sprake van een significante toename in het aantal 
prolifererende cellen in het aangrenzende gedeelte van het bestralingsveld, I 
week na een dosis van 22 Gy, hetgeen duidt op een verschillend 
reaktiemechanisme na bestraling bij jonge en oude dieren. De vroege 
proliferatie werd tevens teruggevonden in een significante toename van het 
aantal endocriene cell en in de crypten van de darm, aangrenzend aan het 
bestralingsveld bij de oude ratten, 52 weken na bestraling. Deze entero-
endocriene celproductie wordt beschouwd als een gevolg van de celproliferatie. 
De incidentie van ernstige schade aan de bloedvaten van de endeldarm, zoals 
occlusie, was significant hoger in de oudere groep, waarbij deze schade ook 
eerder optrad dan in de jongere dieren. Echter aIle gevonden (kleine) 
verschillen tussen de beide leeftijdsgroepen tijdens de vroege tijdpunten, lei den 
niet tot significante verschillen op de latere tijdstippen waarbij ook de 
overleving van de dieren op de langere termijn vergelijkbaar was. Deze studies 
steunen de veronderstelling dat tolerantie voor radiotherapie op oudere leeftijd 
afneemt niet. Meer experimentele en klinische data met betrekking tot de relatie 
tussen leeftijd en tolerantie voor bestraling zijn noodzakelijk. Klinische trials 
waaraan ook oudere patienten mogen deelnemen, eventueel met modificatie van 
de eindpunten, kunnen belangrijke vraagstukken van de geriatrische oncologie 
oplossen. 
Hoofdstuk 4: In de radiotherapie hebben de ontwikkeling van 3D-
planningstechnieken en moderne lineaire versnellers de mogelijkheden 
geschapen om de bestralingsvelden zoveel mogelijk aan te passen aan de 
individuele situatie (tumor) van de patient. Dit kan enerzijds leiden tot 
verbeteringen in het sparen van de kritieke organen en anderzijds tot escalatie 
van de dosis in de tumorregio ten einde de overleving te verbeteren. Bij 3D-
planning op basis van een CT is een exacte definitie en intekening van de tumor 
en de omgevende normale weefsels vereist. In dit hoofdstuk wordt een studie 
beschreven met betrekking tot de verschillen in definitie van het Clinical Target 
Volume (CTV) en het Planning Target Volume (PTV) bij een patient met 
baarrnoederhalskanker waarbij een indicatie bestaat voor postoperatieve 
radiotherapie. Zeventien Nederlandse radiotherapeuten namen deel aan deze 
studie; zij definieerden bovenbeschreven volumina en tekenden de volumina 
en/of de bestralingsvelden aan op bijgeleverde simulatiefoto's. Deze volumina 
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werden vergeleken met een referentie PTV, waarvoor data van een groot aantal 
Iymfangiogrammen en CT -scans van vrouwelijke patienten werden gebruikt. Er 
bleek geen consensus te bestaan met betrekking tot de definitie van het electieve 
deel van het CTV. De bestralingsvelden welke waren aangetekend op de 
simulatiefoto's, veelal gebaseerd op de anatomie van de benige structuren, 
waren in 41 % niet adequaat ter hoogte van de parametria in vergelijking met 
het referentie-PTV en in 40 % van de gevallen waarbij werd aangegeven dat de 
para-aortale klierketen tot het CTV behoorde, ter plaatse inadequaat. Meer 
standaardisatie in definitie van het CTV voor de diverse tumoren is 
noodzakelijk, met name voor het elektieve gedeelte van het CTV. 
In hoofdstuk 5 wordt een vergelijking gemaakt tussen een conventionele en een 
3D-conformatie bestralingstechniek bij 15 patienten met baarmoederhalskanker, 
stadium Ib-IIa, met histologisch bewezen Iymfkliermetastasen. Met behulp van 
de conformatie bestralingstechniek was het mogelijk de gemiddelde kans op 
normale weefselschade (NTCP), voor zowel de dunne darm als de endeldarm, 
significant te reduceren. Verder onderzoek naar de klinische relevantie van 
dergelijke technieken ten einde de toxiciteit te verminderen, is noodzakelijk. 
Hoofdstuk 6: Bij bestraling van tumoren in het kleine bekken kan de patient in 
buikligging gepositioneerd worden in een zogenaamd belly board. Dit heeft als 
doel om (een gedeelte van) de dunne darmen te sparen doordat ze verplaatsen 
naar de regio boven het bestralingsveld, waar een opening in het board gemaakt 
is. In dit hoofdstuk wordt een studie beschreven naar de reductie van volume 
van dunne darm binnen de bestralingsvelden van gynaecologische patienten, 
gebruik makend van het belly board. Er bleek sprake van een gemiddelde 
reductie van het volume dunne darm binnen bestraald gebied van 64 % (95 % 
CI 56- 72 %) in buikligging in het board, vergeleken met positionering in 
rugligging op de bestralingstafel. Gelijktijdig werd de nauwkeurigheid van de 
positionering in het belly board onderzocht waarbij gebruik gemaakt werd van 
electronische megavolt afbeeldingsapparatuur en een zogenaamd off-line 
verificatie- en correctieprotocol. Bij een dergelijk protocol ter verificatie van de 
positionering wordt het megavoltbeeld na de betreffende fractie geanalyseerd en 
een eventuele correctie bij de volgende behandeling uitgevoerd. De gemiddelde 
dagelijkse random variatie in de positionering bleek klein (1 SD < 3 mm), 
hetgeen een significante verbetering betekende ten opzichte van de variaties in 
rugligging bij dezelfde patientengroep uit eerdere studies binnen ons instituut. 
De gemiddelde systematische fouten in x-, y-, en z-richting in buikligging in het 
belly board waren eveneens klein (1.7- 2.1 mm), waarbij een aktie-drempel van 
12 mm werd gehanteerd voordat een correctie van de positionering werd 
uitgevoerd. 
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Hoofdstuk 7: Wanneer de positionering van een patient gecontroleerd en 
eventueel gecorrigeerd wordt nadat een klein gedeeJte van de betreffende fractie 
is gegeven, waarna de rest van de fractie wordt voltooid, spreekt men van 
zogenaamde on-line verificatie en correctie, Dit kan lei den tot een reductie van 
de marge tussen CTV en PTV welke onder andere aangebracht wordt voor de 
onnauwkeurigheid van de positionering, Een significante reductie van deze 
marge zou kunnen lei den tot een reductie in toxiciteit en eventueel tot een 
verhoging van de dosis in de primaire tumorregio, In dit hoofdstuk wordt een 
studie beschreven waarbij on-line verificatie en correctie werd toegepast bij 
gynaecologische patienten, De initiele aktie-drempel was 4 mm; de random 
variaties waren 1,5- 2 mm, De systematische variaties konden worden 
gereduceerd tot < 1 mm, hetgeen een reductie in de marge van CTV tot PTV 
van 4 mm mogelijk maakte (van 7 naar 3 mm), Echter, in vergelijking met off-
line correctie, kost on-line correctie meer tijd bij de lineaire versneller 
gedurende de behandelingen, Bovendien is het meer bel as tend voor de patient 
door de herhaaldelijke onderbrekingen van de behandeling, On-line correctie 
van de positionering dient derhalve gebruikt te worden in gevallen waarbij 
sprake is van grote random fouten, 
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Aan het einde van de rit heb ik zeker de behoefte om een aantal mensen in het 
bijzonder te bedanken, niet aileen omdat dat op deze plaats gebruikelijk is, maar 
vooral omdat zonder hen dit boekje er nooit gekomen was. 
In de eerste plaats de leden van de "kleine" promotiecommisie voor het 
kritisch lezen van het manuscript en voor de zinvolle suggesties van jullie kant. 
De voorzitter van deze commissie en tevens mijn promotor, Peter Levendag, 
zou ik met name willen danken voor het commentaar op mijn eerste schreden 
op het publicatiepad en de manier waarop hij er steeds in geslaagd is om 
eventuele twijfel of het ooit af zou komen, nooit te ventileren. Ook de leden van 
de "grote" commissie ben ik dankbaar voor het leeswerk en het komen naar 
mijn promotie. Een van hen zou ik graag met name willen noemen, namelijk 
Loes van Velthuysen. Loes, ik ben er altijd enorm blij mee geweest dat je de 
taak van prof. Bosman na diens vertrek over wilde nemen. Van je commentaar 
op mijn beoordeling van de coupes heb ik veel geleerd, hoewel ik weI eens 
gedacht heb dat ik het onderscheid tussen veranderd en toegenomen collageen 
nooit zou leren. Het was voor mij vanzelfsprekend na onze wekelijkse sessies 
op de EUR (en tijdens je zwangerschapsverlof aan jouw keukentafel), dat ik 
voor het onderzoek met je mee zou gaan naar het NKI. De files heb ik met 
plezier getrotseerd daarvoor. Onze discussies over de ratten (die jij met 
regelmaat muizen bleef noemen!) heb ik zeer gewaardeerd en zal ik niet snel 
vergeten. 
Toch hebben we al dat werk aileen kunnen verzetten door het fantastische 
en zeer secure analistenwerk van Christel van Hooije. Christel, ik heb heel goed 
kunnen begrijpen waarom je in '98 verkast bent naar het Datamanagement, 
maar ik heb het weI heel jammer gevonden. 
Cindy Noordermeer zou ik eveneens willen bedanken voor haar inzet 
tijdens haar stageperiode als analist in opleiding. Van de Radiobiologie ben ik 
dan verder ook veel dank verschuldigd aan Gerard van den Aardweg, niet in de 
laatste plaats voor het kritisch lezen van de manuscripten over de ratten. 
Tijdens het radiobiologisch onderzoek ben ik min of meer door toeval in de 
MMSO-groep terechtgekomen die onder de bezielende leiding van Ben Heijmen 
een goede stimulans voor het ontwikkelen van de conformatie radiotherapie op 
onze afdeling was en is. Van de discussies in deze werkgroep over research en 
toepassing in de kliniek heb ik veel geleerd. De leden van de gyn-
conformatiegroep, waaronder Merik Seven, Jan van Santvoort, Robert Kaatee en 
later ook Marjolein Verstraate ben ik dank verschuldigd voor de bergen werk die 
verzet zijn en hun geduld als ik weer eens te laat op de bespreking verscheen. 
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Sandra Quint zou ik graag speciaal willen noemen. San, de manier waarop jij 
steeds weer energie voor het doen van research put uit de patienten die je 
dagelijks meemaakt en de toxiciteit die je bij hen ziet, vind ik heel bijzonder. Je 
weet die energie om te zetten in heel gedegen onderzoek en dat ook nog met een 
hoop 101. Ik hoop dat je dit werk nog lang zuIt blijven doen. Ook Hetty van den 
Berg zou ik met name willen noemen voor de goede en gezellige samenwerking 
bij zowel de landelijke studie als het belly board onderzoek. Je vertrek naar 
Eindhoven was een logische stap, maar kwam weI hard aan! 
De basis voor het belly board-onderzoek werd gelegd in de MY A-groep, waar 
ik eveneens per toeval ingerold ben. Met name Andries Visser, Hans de Boer en 
Lars Murrer hebben mij hierin wegwijs gemaakt en geholpen met zinvolle 
discussies. John Sornsen de Koste heeft op zijn minst een eervolle verrnelding 
verdi end voor alle hulp bij de analyse van en gedachtewisseling over de belly 
boardpatienten. 
Joep Stroom zou ik willen bedanken voor de samenwerking bij het on-
linewerk, niet in de laatste plaats voor zijn geduld met aile klinische aanvullingen 
en suggesties bij het artikel, welke elkaar meer dan eens tegenspraken. Binnen de 
MV A -groep heb ik verder veel geleerd over de klinische implementatie van 
Carien Creutzberg. Zij bleek daarnaast ook een gewaardeerde collega en een 
vriendin van onschatbare waarde. 
Al mijn collega's radiotherapeuten zou ik graag willen danken voor hun 
oprechte belangstelling ten aanzien van mijn vorderingen gedurende de afgelopen 
jaren en zonder daarbij iemand teniet te willen doen, is het op zijn plaats speciaal 
Margreet Baaijens te bedanken voor de steun op aile fronten welke ik steeds van 
haar gekregen heb. Samen met Carien is zij ook nog eens bereid geweest om 
paranymf bij deze promotie te zijn, hetgeen vooraf al veel extra gezelligheid heeft 
gebracht. 
Wendy Smit en Jeannette Schilperoord zou ik graag willen bedanken voor 
hun aItijd aanwezige bereidheid om "klaar te staan" en hun hulp bij aile 
correspondentie rondom deze promo tie. 
Hans Vuik en Hans Kneefel van het Audio-visueel Centrum, bedankt voor 
jullie bereidheid om altijd weer onder zekere tijdsdruk aan al onze wensen 
tegemoet te komen. Het is echt fantastisch watjullie doen. 
De medewerkers van de bibliotheek, met name mw. M. Westerhout, 
duizendmaal dank voor het opzoeken van relevante literatuur. 
Veel dank ben ik verschuldigd aan mijn ouders die mij enerzijds steeds wisten 
te stimuleren op momenten waarop dat hard nodig was en anderzijds altijd een 
luisterend oor hadden op momenten waarop dat misschien niet altijd nodig was. 
Helaas heeft mijn vader deze kroon op het werk en ook eerdere momenten van 
trots niet meer mogen meemaken. 
Tot slot, Stef, jou in het bijzonder wil ik bedanken voor alles wat je in de 
afgelopen jaren hebt betekend. Niet alleen je mentale steun was onmisbaar, doch 
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ook je hulp bij mijn eerste schreden op het computerpad, bij mislukte figuren en 
bij het scannen van suboptimale foto's, zal ik nooit vergeten. En dan zullen we het 
maar niet hebben over een finale versie van het proefschrift op een kapotte harde 
schijf gedurende de nachtelijke uurtjes. Je moet toch best weI eens getwijfeld 
hebben of het ooit af zou komen, maar hebt dit nooit laten blijken. Mijn dank is 
heelgroot. 
Last but not least, Juana en Ivan, bedankt voor jullie altijd zeer nadrukkelijke 
aanwezigheid, de positieve energie die jullie geven en de talloze momenten van 
slappe lach die ik met jullie mag beleven. 
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Manouk Olofsen- van Acht werd op I oktober 1960 geboren te Sittard. In mei 
1979 behaalde zij het VWO diploma aan het Bisschoppelijk College Schondeln 
te Roermond. Zij studeerde gedurende een tweetal jaren Biologie aan de 
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